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Abstract 
Diffusible proteins regulate neural development at a variety of 
stages. Using a novel neuronal culture assay, I have identified several 
cytokines that regulate the expression of neurotransmitters and 
neuropeptides in sympathetic neurons. These cytokines fall into two 
families. The first group is termed the neuropoietic cytokines, while 
including CDF/LIF, CNTF, OSM and GPA, induces expression of the same 
set of neuropeptide mRNAs in cultured sympathetic neurons. These four 
factors not only exhibit similar biological activities; they also share a 
predicted secondary structure and bind to a signal-transducing receptor 
subunit in common with IL-6 and IL-11. The latter two cytokines display a 
weaker activity in this assay. In addition, I find that several members of 
the TGF-~ superfamily, activin A, BMP-2, and BMP-6, have a selective 
overlap with the neuropoietic family in the spectrum of neuropeptides 
that these cytokines induce in sympathetic neurons. Different patterns of 
neuropeptides induced by the TGF-~ family members, however, 
demonstrate that the activities of these cytokines are distinct from those of 
the neuropoietic family. Another 30 cytokines are without detectable effect 
in this neuronal assay. 
Activin A induces a set of neurotransmitters and neuropeptides that 
is somewhat similar to the phenotype of sympathetic neurons innervating 
sweat glands in rat footpads . In situ hybridization and RNase protection 
were carried out to test whether activins were involved in the phenotypic 
transition when sympathetic neurons contact sweat glands. I find that 
activin mRNA is present in both cholinergic and noradrenergic targets. 
Moreover, homogenates of footpads do not contain activin-like activity in 
the neuronal assay in vitro. Taken together, these data do not support 
activins as the best candidates for the sweat gland factor. 
Several novel factors that regulate neuropeptide expression exist in 
heart cell conditioned medium. I attempted to purify these factors in 
collaboration with Dr. Jane Talvenheimo. Our results suggest that these 
factors are sensitive to the storage conditions used. Several modifications 
of purification strategy are discussed. 
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CHAPTER 1. Introduction 
2 
The development of the nervous system involves several stages, from 
initial proliferation of progenitor cells, to differentiation and migration of 
these cells, through the outgrowth of neurites and formation of synapses, to 
the rearrangement of connections. The goal of this sequence is to build an 
appropriate information network by which neurons can communicate with 
their targets to control body functions. The task of building this network is 
tremendously complex, given the enormous number of neurons in vertebrates, 
and their morphologically and molecularly extreme diversity. Mechanisms 
for each step are, however, beginning to be elucidated. For example, the 
variety of cell types is controlled, in part, by cell cycle-dependent intrinsic 
changes (McConnell, 1992), contact with extracellular matrix and cell surface 
molecules (Bronner-Fraser, 1992; Stemple and Anderson, 1993) and diffusible 
proteins (Jessell and Melton, 1992). 
In addition to the physical meeting of appropriate partners, functional 
communication between neurons and their targets requires that the 
presynaptic expression of neurotransmitters and neuropeptides is matched 
with the proper receptors for decoding these signals postsynaptically. There 
are approximately a dozen classical transmitters and over 75 neuropeptides 
currently known, and new candidates are continuously being discovered in 
the nervous system. A recent example is agmatine, which binds to <X2-
adrenergic and imidazolin receptors and stimulates release of catecholamines 
from adrenal chromaffin cells (Li et al., 1994). Not only is there a very large 
repertoire of transmitters and neuropeptides, but individual neurons produce 
reproducible combinations of these molecules (Gibbins and Morris, 1987; 
Lundberg and Hokfelt, 1986), which further complicates the developmental 
task. How neurons "choose" a particular set of transmitters and 
neuropeptides is therefore an intriguing problem. Recent studies have 
highlighted how neuronal phenotypic decisions can be based on neuronal cell 
lineage as well as on environmental cues and instructive differentiation 
signals (Patterson and Landis, 1992). 
Phenotype based on lineage 
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Because of the ease in identifying specific stem cells and following their 
progeny during development, insects have provided valuable insights into the 
role of cell lineage in determining transmitter phenotype. In the locust, 
Taghert and Goodman (1984) E reported that only a subpopulation of the 
progeny of neuroblast 7-3 uses serotonin as a transmitter. Neuroblast 7-3 
divides three times in situ, generating six neurons. However, only the 
progeny of the first two cell divisions express serotonin, suggesting that birth 
order is involved in establishing this phenotype. The expression of GABA is 
also confined to particular progeny in the thoracic ganglion of the tobacco 
hornworm (Witten and Truman, 1991a). These two examples illustrate that a 
particular transmitter may be restricted to subsets of neurons in discrete 
lineages. Further evidence that cell lineage is involved in phenotypic choice 
was demonstrated by ablating of neuroblasts that give rise to progeny 
expressing specific transmitters. Work by Sulston and Horvitz (1977) in the 
nematode, Stuart et al. (1987) in the leech, Targhert and Goodman (1984) in 
the locust, and Witten and Truman (1991b) in the moth showed that, if the 
appropriate neuronal stem cells are removed, the nervous system does not 
compensate for the loss, and the transmitter phenotype (dopamine, GABA or 
serotonin) disappears from that region of the central nervous system (CNS). 
Studies using retroviruses as cell lineage tracers have shed light on the 
role of lineage in determining neuronal identity in the vertebrate CNS. In the 
cerebral cortex there are two main populations of neurons, the pyramidal and 
the nonpyramidal cells, which respectively adopt glutamate and GABA as 
their transmitters (Fagg and Foster, 1983). Clonally related neurons, marked 
by retrovirus injection into rat telencephalic ventricles at any time point 
between embryonic day 14 and day 19, display remarkable homogeneity, 
expressing either of the two types of morphology and its corresponding 
transmitter (Mione et al., 1994). This restriction of morphology and 
transmitter is specific to those traits, as clonal relatives express different 
calcium binding proteins. Since clonally-related neurons in the cerebral cortex 
display widespread migration and are presumably exposed to different 
environments (Walsh and Cepko, 1992), this result suggests that commitment 
of cortical neurons to a particular phenotype takes place in the ventricular 
zone, where progenitor cells are still actively dividing, and that lineage plays a 
role in determining this aspect of phenotype in cortical neurons. 
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Influence of environmental signals 
Although lineage tracing experiments reveal that neuronal properties 
can be specified at the progenitor cell stage, a role for cellular interactions in 
specifying phenotype is not ruled out. In the Drosophila ommatidium, 
differentiation choices are invariant under normal conditions. Nonetheless, 
cell-cell interactions are required to generate the final identical pattern of 
photoreceptor cells (Cagan and Zipursky, 1992). Analysis of the vertebrate 
peripheral nervous system (PNS) further illustrates that environmental cues, 
especially interactions between neurons and their targets, modulate neuronal 
phenotypic choices (Patterson, 1978; Patterson and Landis, 1992; Patterson and 
Nawa, 1993). 
Evidence supporting that environmental cues influence neuronal phenotype 
The avian parasympathetic ciliary ganglion contains two distinct 
populations of neurons: choroid neurons, which innervate vasculature smooth 
muscle in the eye's choroid layer, and ciliary ~eurons, which innervate 
striated muscle of the ciliary body and iris (Marwitt et al., 1971). Both 
populations of neurons utilize acetylcholine (ACh) as a transmitter (Martin 
and Pilar, 1963; Meriney and Pilar, 1987). However, choroid neurons, but not 
ciliary neurons, express somatostatin (SOM) (Epistein et al., 1988). Since both 
neurons are derived from the neural crest (Narayanan and Narayanan, 1978), 
develop presumably in the same ganglionic environment, and receive the 
same preganglionic input from the Edinger-Westphal nucleus, the expression 
of SOM in the choroid neurons suggests that the target tissues are involved in 
generating the difference in neuropeptide expression. The expression of ACh 
may also be specified by the target, because the developmental increase in the 
ACh-synthetic enzyme (choline acetyl transferase; ChAT) activity coincides 
with innervation of the eye (Coulombe and Bronner-Fraser, 1990). Different 
phenotypic traits expressed in neurons with soma in the same location but 
with axons innervating different targets also occur in sympathetic ganglia 
(Elfvin et al., 1993; Gibbins, 1990). For instance, neurons in the superior 
cervical ganglion sending axons to blood vessels usually contain NPY, but 
those with axons innervating salivary glands and fat cells do not, even though 
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both populations of neurons use noradrenaline as a transmitter (Cannon et al., 
1986). Thus target tissues may induce some neuronal traits de novo. 
One of the most intensively studied examples is the sympathetic 
innervation of sweat glands in the rat; these neurons switch phenotypes from 
noradrenergic to cholinergic when their axons reach the target, demonstrating 
postmitotic plasticity (Landis, 1990). Before sympathetic axons first contact 
the developing sweat gland in neonatal rats, they exhibit catecholamine 
histofluorescence and express the noradrenaline synthetic enzymes, tyrosine 
hydroxylase (TH) and dopamine f)-hydroxylase (DBH). As the gland 
innervation matures, catecholamine histoflurescence diminishes and 
expression of TH and DBH decreases gradually (Landis and Keefe, 1983). At 
the same time, these axons begin to express ACh and novel neuropeptides. 
ChAT is first detectable at postnatal day 11 (Pll) (Leblanc and Landis, 1986) 
and vasoactive intestinal peptide (VIP) and calcitonin gene-related peptide 
(CGRP) immunoreactivities can be demonstrated at P10 and P21, respectively 
(Landis et al., 1988). The induction of these neuropeptides is specific, because 
there is no detectable expression of neuropeptide Y (NPY), somatostatin 
(SOM), substance (SP), or leu- and met-enkephalin (ENK) in either developing 
or mature sweat gland axons (Landis et al., 1988). The close association in the 
appearance of ChAT and VIP raises the possibility that these two genes are 
regulated coordinately, while expression of CGRP may be regulated by a 
different mechanism (Patterson and Landis, 1992). Several studies indicate 
that this transition occurs in a single population of axons. First, the axons 
innervating sweat glands retain TH and DBH immunoreactivities and the 
catecholamine uptake system in adulthood, although at much reduced levels. 
Thus, coexistence of cholinergic and noradrenergic traits in single axons can 
be detected during the phenotypic transition (Schotzinger and Landis, 1988). 
Second, the expression of ChAT and VIP is not observed in the adult glands if 
neonatal rats are treated with 6-hydroxydopamine to destroy 
catecholaminergic neurons. This indicates that cholinergic and YIP-positive 
neurons are derived from initially catecholaminergic neurons (Yodlowski et 
al., 1984). 
Transplantation as a tool to define neuronal plasticity and environmental influences 
6 
The role of the sweat gland in regulating the transmitter and 
neuropeptide phenotype of innervating sympathetic axons has been further 
explored with transplantation experiments. When the superior cervical 
ganglion (SCG), which contains noradrenergic neurons and does not innervate 
sweat glands normally, is transplanted to the anterior chamber of the eye 
together with developing sweat glands, the neurons initially exhibit 
catecholamine histofluorescence that declines with further development. 
After four weeks, ChAT and VIP immunoreactivities become evident in these 
neurons (Stevens and Landis, 1990). These results suggest that, as in the 
neurons that innervate sweat glands in situ, noradrenergic traits are 
suppressed and cholinergic function is induced in SCG neurons upon 
innervating the glands in the eye. Moreover, cross-innervation experiments 
provide direct evidence for the role of the target. When footpad tissue 
containing sweat glands is transplanted in place of hairy skin that normally 
receives noradrenergic sympathetic innervation, sympathetic axons 
innervating sweat glands express cholinergic traits four weeks later 
(Schotzinger and Landis, 1988). Conversely, if sweat glands are replaced with 
the parotid gland, a target of noradrenergic sympathetic neurons, the 
innervation of the parotid in the footpad does not display a cholinergic 
phenotype. Instead, these sympathetic neurons maintain the noradrenergic 
phenotype, which they would have lost during normal development 
(Schotzinger and Landis, 1990). Thus, the expression of cholinergic properties 
in the sweat gland innervation depends on the presence of this particular 
target, and sweat glands are able to alter the phenotype in sympathetic 
neurons that do not normally contact the glands (Landis, 1990). This 
phenomenon that targets have effects on neuronal phenotype is not restricted 
to vertebrates. Similar transplantation studies also demonstrate that the 
morphological and physiological properties of Retzius neurons in the leech 
are determined by their peripheral targets (French and Kristan, 1992). 
Phenotypic plasticity and target influences are not restricted to the 
embryo or to the young animal. When skin sensory fibers are made to 
innervate muscle in adult rats, these axons lose substance P (SP) 
immunoreactivity. Conversely, SP immunoreactivity appears if muscle 
sensory axons are made to innervate skin (McMahon and Gibson, 1987). 
When adult SCG neurons are placed in culture in the presence of heart cell 
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conditioned medium, these neurons change phenotype from noradrenergic to 
cholinergic (Patterson, 1978). Thus, neurons can respond to environmental 
cues in the adult animal. 
Further evidence supporting the role of environmental influences is 
provided by results from other transplantation experiments. For example, 
when postmitotic cholinergic ciliary neurons are labeled and injected into the 
chick embryo in the region of active neural crest migration, some of these cells 
migrate to adrenal medulla and sympathetic ganglia primodia and express 
catecholamine histofluorescence (Coulombe and Bronner-Fraser, 1986). In the 
rat embryo, neocotical neurons transiently express TH. If early embryonic 
neocotical neurons are transplanted into adult neocortex, they continually 
express TH (Park et al., 1986), suggesting inhibitory factors may be present in 
the perinatal but not adult neocortex that suppress TH expression. 
Implantation and integration of multipotent neural cell lines into different 
regions of the brain in neonatal rodents has recently been demonstrated. Most 
strikingly, the grafted cells differentiate into neurons or glia, and exhibit 
appropriate morphologies and intercellular connections, according to the 
developmental stage and site of injection (Renfranz et al., 1991; Snyder et al., 
1992). This region-specific differentiation of multi potent cells suggests that 
commitment and differentiation of progenitor cells in the CNS is controlled in 
part by local cell-cell interactions. 
Molecules that specify transmitter and neuropeptide phenotype 
Several factors have been characterized in terms of their ability to 
modulate neuronal phenotype. These include small molecules, such as 
hormones, peptides and transmitters, as well as proteins, such as cytokines 
and growth factors (Patterson, 1993; Patterson and Landis, 1992; Patterson and 
Nawa, 1993). 
The effects of small molecules 
Changes in expression of transmitters and neuropeptides have been 
correlated with natural fluctuations of hormones during metamorphosis and 
the estrous cycle. In the hawkmoth, Manduca sexta, abdominal lateral 
neurosecretory cells produce both a cardioacceleratory peptide and a low level 
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of the tanning hormone, bursicon. During metamorphosis, neuronal gene 
expression changes so that only bursicon is produced by these neurons 
(Tublitz and Sylwester, 1990). This alteration is initiated by both prepupal 
peaks of 20-hydroxyecdysone and a decline of the juvenile hormone (Weeks 
and Levine, 1990). In female rats, the expression of galanin (GAL) in the 
luteinizing hormone-releasing hormone (LHRH)-containing neurons of the 
medial preoptic area is regulated according to the estrous cycle. These 
neurons express higher levels of GAL during proestrous than during estrous, 
while expression of co-localized LHRH does not show cyclic changes 
(Merchenthaler et al., 1991). Ovariectomy results in a significant decrease in 
the number of cells expressing GAL, and estradiol treatment of such animals 
restores the number of GAL-containing cells to normal levels. In male rats, 
estradiol injection does not enhance expression of GAL in LHRH-containing 
neurons. Apparently, neonatal hormonal imprinting is involved in the 
process (Merchenthaler et al., 1993). A similar example is the differential 
regulation of cholecystokinin and SPin the amygdala by estrogen (Simerly, 
1990). 
Evoked activity through release of transmitters and neuropeptides from 
presynaptic neurons can also influence postsynaptic neuronal phenotype. For 
example, olfactory afferent innervation is important in the maintenance of the 
dopamine phenotype of olfactory bulb neurons. Deprivation of odorant 
stimulation decreases TH expression without cell loss or change of expression 
of GABA or aromatic L-amino acid decarboxylase that coexist with m in 
olfactory bulb neurons (Baker, 1990). This in vivo manipulation can be 
replicated in vitro. m expression is enhanced when olfactory bulb neurons 
are co-cultured with olfactory epithelial neurons. This effect can be mimicked 
by administrating CGRP, which is a peptide produced and released by 
olfactory epithelial neurons (Denis-Donini, 1989). 
In tissue culture, constant depolarization by elevated extracellular 
potassium concentration increases the expression of m, ENK, NPY, SOM, VIP 
in various neurons (Goodman, 1990; Morris et al., 1988; Tolon et al., 1994; 
Zigmond, et al., 1989). In denervated sympathetic ganglia, however, 
depolarization blocks the induction of SP expression (Roach et al., 1987). 
Direct application of transmitters or neuropeptides can also affect neuronal 
phenotype. Adding noradrenaline to cultured rat pineal cells suppresses the 
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expression of serotonin (Araki and Tokunaga, 1990). Noradrenaline has a 
positive feedback effect on its synthesis by upregulating expression of TH and 
DBH in cultured quail neural crest cells (Zhang and Sieber-Blum, 1992). 
CGRP, VIP, SP, SOM and substance K also regulate TH activity in 
catecholaminergic neurons (Denis-Donini, 1989; Friedman et al., 1988; Kessler 
et al., 1983; Zurn et al., 1993). In adrenal chromaffin cells, factors differentially 
regulate expression of ENK and the adrenaline-synthesizing enzyme, 
phenylethanolamine N-methyltransferase (PNMT). The expression of PNMT, 
but not ENK, is induced by glucocoticoids. Conversely, VIP, through an 
increase of intracellular cAMP, induces ENK but not PNMT (Wan et al., 1991). 
A peptide of 11 amino acids has been purified and sequenced from 
hippocampal extracts by virtue of its ability to stimulate ACh synthesis in 
medial septal nuclei in explant culture. This peptide is designated as 
hippocampal cholinergic neurostimulating peptide (HCNP). Chemically-
synthesized HCNP induces ACh synthesis of cultured medial septal nuclei in 
a dose-dependent manner, but has no effect on cultures of corpus striatum or 
anterior spinal cord (Ojika et al., 1992). Since explants were used in the 
experiment, the effect of HCNP could be due to an indirect effect via glia or to 
differential survival effect on cholinergic neurons. The gene for HCNP has 
not been cloned yet, and its tissue distribution has not been published. 
The effects of cytokines and growth factors 
Given the evidence that target tissues can control the transmitter 
phenotype of the neurons that innervate them, it is reasonable to assume that 
there are target-derived factors that act as trans-synaptic, retrogradely 
transported, phenotype-specifying agents. Soluble factors are more likely in 
some cases, because neurons do not physically contact certain target tissues, 
such as sweat gland cells (Landis and Keefe, 1983; Quick et al., 1984; Uno and 
Montagna, 1975). Cell culture of neurons has been used to characterize and 
identify several factors that regulate neuronal gene expression. These factors 
include members of the neurotrophin, neuropoietic, and TGF-~ families. 
Neurotrophins. Originally identified as a survival factor for sensory and 
sympathetic neurons (Levi-Montalcini and Hamburger, 1951), nerve growth 
factor (NGF) was the first member of the neurotrophin family that now 
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contains at least four proteins (Altin and Bradshaw, 1993; Thoenen, 1991). In 
addition to acting as a survival factor, NGF can enhance neuronal 
differentiation and trigger mitosis in chromaffin cells (Claude et al., 1988; 
Frodin and Gammeltoft, 1994; Stemple et al., 1988). Neurotrophins can also 
act as instructive factors to regulate expression of transmitters and 
neuropeptides. For example, NGF selectively induces the expression of 
particular neuropeptides in sensory neurons (Lindsay and Harmar, 1989). 
Similarly, brain-derived neurotrophic factor induces the expression of SOM 
and NPY by directly acting on cultured cortical neurons without affecting 
neuronal survival (Nawa et al., 1993). 
Neuropoietic cytokines. In addition to the neurotrophins, several other 
families of proteins have both neuronal survival and differentiation activities. 
The cholinergic neuronal differentiation factor (CDF) is a protein initially 
purified from heart cell conditioned medium by virtue of its ability to change 
cultured sympathetic neurons from a noradrenergic to a cholinergic 
phenotype without affecting survival or growth (Fukada, 1985; Patterson and 
Chun, 1977). When the eDNA for CDF was cloned and sequenced, it turned 
out to be identical to leukemia inhibitory factor (UF) (Yamamori et al., 1989). 
CDF /LIF is a pleiotrophic cytokine, regulating cell proliferation and 
differentiation in a variety of tissues (Metcalf, 1992). CDF /LIF has recently 
been shown to also act as a survival factor for embryonic sensory and motor 
neurons (Martinou et al., 1992; Murphy et al., 1991). Conversely, ciliary 
neurotrophic factor (CNTF), which was characterized as a survival factor for 
ciliary neurons (Alder et al., 1979), was shown to switch cultured sympathetic 
neurons from a noradrenergic to a cholinergic phenotype (Saadat et al., 1989). 
In addition to inducing ChAT and decreasing TH expression, both CDF /LIF 
and CNTF show very similar activities on neuropeptide expression, inducing 
SP, SOM, and VIP in cultured sympathetic neurons (Nawa et al., 1991; Nawa 
et al., 1990; Rao et al., 1992d), and acting as survival factors for motor neurons 
(Arakawa et al., 1990; Martinou et al., 1992; Sendtner et al., 1990). In addition, 
CDF /LIF and CNTF sustain survival and differentiation of glial cells. The 
oligodendrocyte-type-2 astrocyte (0-2A) progenitor cells in the optic nerve 
and cerebral cortex can develop into oligodendrocytes or type-2 astrocytes 
under appropriate conditions (Raff, 1989). CNTF triggers conversion of 
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progenitor cells to type-2 astrocytes (Hughes et al., 1988), although this effect 
is transient and other factors are required to drive the process to completion. 
Both CDF /LIF and CNTF also promote survival and maturation of cultured 
oligodendrocytes, and induce myelin basic protein expression (Barres et al., 
1993; Louis et al., 1993). CNTF also mimics the effects of CDF/LIF on 
embryonic stem cells and hepatocytes (Conover et al., 1993; Schooltink et al., 
1992). Despite there being many biological activities in common, the primary 
sequences of CDF /LIF and CNTF contain very limited homology (Lin, et al., 
1989; Stockli et al., 1989; Yamamori et al., 1989). Nonetheless, Bazan (1991) 
predicted that CDF/LIF and CNTF, together with IL-6, oncostatin M (OSM), 
and granulocyte colony-stimulating factor (G-CSF), share similar secondary 
structures (Bazan, 1991). The cloning of receptors for this family showed that 
CDF/LIF, CNTF, IL-6, OSM, and IL-11 utilize the same protein, gp130, as a 
signal transduction subunit in the receptor complex (Gearing et al., 1992; Ip et 
al., 1992; Kishimoto et al., 1994; Yin et al., 1993). In addition, OSM and 
CDF /LIF share the same receptor complex, as OSM competes with CDF /LIF 
for receptor binding with high affinity (Gearing and Bruce, 1991; Gearing et 
al., 1992). Signal transduction pathways involving tyrosine phosphorylation 
have been characterized for these factors (Lutticken et al., 1994; Stahl et al., 
1994), and stimulation of immediate early gene expression has been identified 
(Ip et al., 1992; Kishimoto et al., 1994; Lord et al., 1991; Yamamori, 1991). Not 
surprisingly, CDF /LIF, OSM, IL-6, and IL-11 have similar bioactivities in 
various tissues (Kishimoto et al., 1992). Prior to the present work, however, 
the effects of OSM, IL-6, and IL-11 on neuronal phenotype had not been 
explored in detail. Preliminary result from Rao et al. (1992c) showed that 
OSM induces VIP expression in neuroblastoma cells. 
Three other neuronal differentiation factors are related to CNTF. 
Growth promoting activity (GP A) was purified from chick eye and has the 
same ciliary neurotrophic activity as mammalian CNTF (Eckenstein et al., 
1990). Upon cloning, GPA was found to be approximately 50% identical to rat 
CNTF (Leung et al., 1992). GPA is expressed in chick eye during the period of 
naturally occurring cell death for ciliary neurons that innervate eye muscles, 
and is secreted from transfected cells (Leung et al., 1992). CNTF, on the other 
hand, is not expressed in the embryo, and is not secreted. These differences 
between CNTF and GP A raise the possibility that GP A may not be the chick 
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equivalent of CNTF. Recently, GPA has been demonstrated to have neuronal 
differentiation activity and induce VIP expression in chick sympathetic 
neurons (Heller et al., 1993). Two other proteins related to CNTF are the 
membrane-associated neurotransmitter-stimulating (MANS) factor (Wong 
and Kessler, 1987) and an activity in sweat gland extracts, sweat gland factor 
(SGF) (Rao and Landis, 1990). SGF and MANS have not been sequenced as 
yet. CNTF, MANS and SGF show similar activities on neuronal phenotype in 
cultured sympathetic neurons (Rao et al., 1992a; Rao et al., 1992b). Anti-cNTF 
antisera immunoprecipitate all MANS activity but only part of SGF activity 
(Rao et al., 1992a; Rao et al., 1992b). This raises the possibility that MANS may 
be a membrane-bound form of CNTF, and that there is a distinct, CNTF-like 
neuronal differentiation factor in sweat glands (Rao et al., 1992b; Rohrer, 
1992). The latter notion is supported by biochemical analysis, which indicates 
that SGF is not CDF/LIF or CNTF (Rao,et al., 1992b; Rohrer, 1992). Moreover, 
the innervation of sweat glands is phenotypically normal in CDF /LIF- and 
CNTF- deficient mutant mice (Masu et al., 1993; Rao et al., 1994). 
Interpretation of negative results with these knockout mice is difficult, 
however, given the overlapping activities of multiple factors. A likely 
candidate for the SGF is the mammalian version of GP A. 
Since CDF/LIF, CNTF, GPA, MANS, SGF, IL-6 and IL-11 have 
overlapping activities in a variety of tissues, share a predicted secondary 
structure, and utilize the same receptor subunit as a signal transducer, these 
proteins are grouped together as a family, even though their primary 
sequences are not conserved. The term neuropoietic cytokines is used, 
because they regulate cell differentiation and gene expression both in the 
nervous and hematopoietic systems (Anderson, 1989; Bazan, 1991; Patterson 
and Nawa, 1993). 
TGF-{3 superfamily. The factor likely to be responsible for SOM expression in 
choroid neurons of the chick ciliary ganglion has been identified as activin A 
(Coulombe et al., 1993), a member of the TGF-~ superfamily (Kingsley, 1994; 
Massague, 1990). Activin A message and protein are present in cultured 
ciliary choroid cells, but not in cultured skeletal muscle cells. Follistatin, an 
endogenous activin inhibitor, can block SOM-inducing activity in the choroid 
cell conditioned medium. Furthermore, recombinant activin A can induce 
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expression of SOM in cultured ciliary neurons. Since several members of the 
TGF-~ family are localized primarily in the nervous system (Basler et al., 1993; 
Lee, 1991) or have neurotrophic effects (Lin et al., 1993), this family deserves 
further analysis in neuronal development. 
Other factors. Other known growth factors have effects on neuronal 
phenotype. For example, insulin and insulin-like growth factors induce THin 
cultured embryonic quail dorsal root ganglia (Xue et al., 1988). Both acidic 
FGF and basic FGF can induce a cholinergic phenotype in cultured chick 
sympathetic neurons (Zurn, 1992). Neither of these phenomena has been 
further analyzed to date. A number of additional neuronal differentiation 
factors have been partially purified. Nawa and Patterson (1990) showed that 
two factors biochemically distinct from CDF /LIF exist in heart cell 
conditioned medium; one induces VIP and the other induces SOM in 
sympathetic neurons (Nawa and Patterson, 1990). A factor termed muscle-
derived differentiation factor (MDF) can increase expression of THin several 
cultured CNS neurons without enhancing neuronal survival (Iacovitti, 1991; 
Iacovitti et al., 1992). There is a critical period for neurons to respond to MDF. 
Another muscle-derived factor, ChAT development factor (CDF, note: not the 
same as CDF/LIF), increases the level of ChAT activity in cultured spinal cord 
neurons (McManaman et al., 1988). This protein can selectively rescue motor 
neurons during the period of naturally occurring cell death (McManaman et 
al., 1990), but not other neurons which undergo cell death during the same 
period. CDF is a 22 kDa protein; peptide sequence analysis indicates that it is 
a novel protein (McManaman and Oppenheim, 1993) 
The goal of the present work 
The fact that the cytokine CDF /LIF can act as a growth and 
differentiation factor in the nervous system raises the issue as to whether other 
cytokines and growth factors may have effects on neuronal cells. Indeed, 
several interleukins are now known to have neurotrophic activity (Kamegai et 
al., 1990; Loughlin and Fallon, 1993; Mehler et al., 1993). As in the case of 
neurotrophins and neuropoietic cytokines, these interleukins may also have 
neuronal differentiation activities. To screen for more than 60 known 
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cytokines and growth factors on the neuronal expression of transmitters and 
neuropeptides, a convenient assay was needed. Conventional methods, such 
as radioimmunoassays and metabolic assays, are laborious and time-
consuming. Moreover, such methods screen one phenotypic trait at a time 
and require many thousands of cells for each data point. To resolve this 
problem, I will describe in Chapter 2 a method based on the reverse 
transcription-polymerase chain reaction (RT-PCR) technique to measure the 
expression of 13 genes commonly found in the PNS. The specificity of primers 
will be demonstrated and the conditions of PCR will be defined. The effects of 
CDF /LIF and CNTF on cultured sympathetic neurons are then assessed by 
this assay in order to compare with the results from previous assay methods. 
The effects of 33 cytokines are analyzed with the RT-PCR assay in 
Chapter 3. Evidence is presented to show that CDF /LIF, CNTF, GP A, OSM, 
IL-6 and IL-11 have similar activities on sympathetic neurons. In addition, 
activin A is shown to induce a particular set of neuronal traits that is different 
from that of the neuropoietic cytokines. This result supports our hypothesis 
that there are factors released by target tissues that generate a wide variety of 
neuronal phenotypes. That most cytokines are without detectable activity in 
this assay illustrates the specificity of these effects. 
To further pursue the effects of TGF-P family members on neuronal 
phenotype, TGF-P1, TGF-P3, BMP-2, and BMP-6 were tested and the results 
are described in Chapter 4. Since activins have cholinergic-inducing activity, 
the possibility that these factors are involved in the phenotypic switch that 
occurs in the sweat gland innervation is analyzed by in situ, RNase protection 
and tissue homogenate experiments. The results are presented in Chapter 4 as 
well. 
I also collaborated with Dr. Jane Talvenheirno in an attempt to purify 
novel factors from heart cell conditioned medium. These results are presented 
in Chapter 5. 
Finally, I participated in the cloning of CDF /LIF. The Appendix 
includes a paper describing this effort. 
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on Neuronal Gene Expression 
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Abstract: We describe an assay based on reverse tran-
scription-polymerase chain reaction to detect the expres-
SIOn of mRNAs for a variety of transmitter synthetic en-
zymes and neuropeplldes present at low levels in primary 
neuronal cultures. The assay IS specific for mANA-derived 
templates and is not affected by the presence of genomic 
DNA. Using this method, we demonstrate that cholinergic 
differentiation factor{leukem1a 1nhib1tory factor (CDF/LIF) 
and cil1ary neurotrophiC factor (CNTF) induce mRNAs for 
choline acetyltransferase. somatos tatin, substance P. va-
soactive intestinal polypeptide. cholecystokinin, and en-
kephalin. The induction of cholecystokinin and enkephalin 
by CDF/LIF and CNTF had not been shown previously. 
These data illustrate that the assay can reproduce f1nd1ngs 
obtained with other methods. as well as provide the sensi-
tivity necessary to produce new results. These results 
also extend the overlap of CDF/LIF and CNTF in control-
ling gene expression in cultured sympathetiC neurons. 
supporting the idea that these cytokines may share recep-
tor subunits and signal transductiOn pathways. Key Words: 
Cholinergic differentiation factor- Leukemia inhibitory 
factor-Ciliary neurotrophic factor- Cholecystokinin-
Enkephalin-Choline acetyltrans ferase-Somatostatin-
Substance P-Vasoactive intest1na1 peptide. 
J . Neurochem. 61 , 1349- 1355 (1993). 
Neuronal communication is mediated by approxi-
mately 12 known classical transmitters and over 75 
neuropeptides. As individual neurons are known to 
express several transmitters and as many as eight dif-
ferent neuropeptides, the number of potential combi-
nations is enormous. The choice of which transmit-
ters and neuropcptides to produce is determined by 
the cell's lineage history and environmental influ-
ences (Nawa et al., 1990; Patterson and Landis, 1992; 
Patterson and Nawa, 1993). One of the most exten-
sive analyses of environmental influences on neuro-
nal phenotype involves sympathetic neurons, both in 
culture and in their innervation of various target tis-
sues in vivo (Black et al. , 1987; Hendry and Hill , 
1992). In the latter work, Landis and colleagues (re-
viewed in Landis, 1990) have shown that the pheno-
typic choice made by sympathetic neurons is con-
trolled, in part, by the particular target tissue they in-
1349 
nervate. Moreover. this choice is altered as the 
neurons contact certain targets, such as the sweat 
glands, during normal development. 
Neuronal cultures have been used to identify candi-
date factors that mav mediate this control of neuronal 
gene expression. Cholinergic differentiation factor/ 
leukemia inhibitory factor (CDF/ LIF) was character-
ized and cloned on the basis of its ability to convert 
cultured rat sympathetic neurons from a noradrener-
gic to a cholinergic phenotype (Yamamori et al., 
1989). In addition. CDF/LIF induces the expression 
of substance P (SP). somatostatin (SOM). and vasoac-
tive intestinal polypeptide (VIP) by increasing tran-
scription of these genes (Nawa et al. , 1990, 1991 ). Saa-
dat et al. ( 1989) found that ciliary neurotrophic factor 
(CNTF) can mediate the same noradrenergic-to-cho-
linergic switch of phenotype in these neurons. CNTF 
also alters expression of the same neuropeptides as 
CDF/LIF (Rao et al.. 1992a). Other, as yet unidenti-
fied, proteins can influence neuronal phenotype. For 
example, two proteins in the conditioned medium 
from cultured heart cells selectively induce the ex-
pression of YIP and SOM (Nawa and Patterson, 
1990). Moreover, a protein(s) in sweat gland extracts 
has CDF/LIF-CNTF-Iike effects on these neurons 
(Rao et al. , 1992b; Rohrer, 1992). Identification of 
these factors will enable a further understanding of 
how neuronal phenotype is determined. 
Primary neurons have been used in such assays be-
Received December 4. 1992: rev1sed manuscript received Febru-
ary 10, 1993: accepted February 16. 1993. 
Address correspondence and reprint requests to Dr. P. H. Patter-
son at Division ofB10logy. California Institute ofTechnology, Pasa-
dena, CA 91125, U.S.A. 
AbbreVIations used. CCK. cholecystokinin: CDF/LIF, choliner-
gic differentiation factor/ leukemia inh1b1tory factor: CGRP, calci-
tonin gene-related pepude: ChAT, choline acetyltransferase: 
CNTF. ci liary neurotrophic factor: DYN. dynorphin: ENK. en-
kephalin: GAD65, 65-kDa glutamic ac1d decarboxylase: GAD67, 
67-kDa glutamic ac1d decarboxylase: NPY. neuropeptide Y; RT-
PCR. reverse transcnption-polymerase cham react1on: SOM. so-
matostatin : SP, substance P: TPH . tryptophan hydroxylase; TH, 
tyrosme hydroxylase: VIP. vasoacuve intestinal polypeptide. 
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cause they presumably reflect the response of normal 
neurons more accuratcl~ than do neuronal cell lines. 
This approach does. howe,er. result 1n limiting 
amounts of material for the assays. One way to cir-
cumvent this problem is to 111crease the sensiti vity of 
the assays for particular transmitters and neuropep-
tides. In this report. we present a new approach based 
on reverse transcription-polymerase chain reaction 
(RT-PCR) that enables us to follow simultaneously 
the expression of mRNAs for 13 transmitters/neuro-
peptides in small numbers of neurons. Using this as-
say, we demonstrate that CDF/LI F and CNTF induce 
expression of mRNAs for choline acetyltransferase 
(ChAT), SP, YIP, cholecystokinin (CCK). and en-
kephalin (ENK) in cultured sympathetic neurons. 
The induction of the latter two neuropeptides by 
CDF/LIF and CNTF has not been shown previously. 
As small numbers of neurons and minimal amounts 
of factors are required in the assay. and numerous 
genes can be analyzed at the same time, this PCR-
based method may"facihtate identification of new neu-
ronal differentiation factors. 
MATERIALS AND METHODS 
Animals and reagents 
Neonatal Sprague-Dawley rats were purchased from Si-
monsen Laboratories (Gi lroy, CA. U .S.A.). Most of there-
agents for tissue culture. Superscript reverse transcriptase 
(RTase), and 1-kb DNA marker were purchased from 
GIBCO/BRL (Grand Island. NY. U.S.A .). Transfern n was 
obtained from Calbiochem (La Jolla. CA. U.S.A.). Nerve 
growth factor, glycogen. dA TP. dCTP. dGTP. and dTTP 
were purchased from Boehringer Mannheim (Indianapolis, 
IN, U.S.A.). RNase inhibitor (RNasin) and Taq DNA poly-
merase were purchased from Promega (Madison. WI, 
U.S.A.). Oligo dT was obtained from Pharmacia (Piscata-
way, NJ, U.S.A.). Primers were synthes1zed in the Biopoly-
mer Synthesis and Analvsis Resource Center at California 
Institute of Technology: Pasadena. CA. U.S.A. All other 
reagents were purchased from Sigma (St. Louis. MO. 
U.S.A.). Human recombinant CDF/LIF and rat recombi-
nant CNTF were kindly prov1ded b~ Dr. Babru Samal and 
colleagues at Amgen, Inc. (Thousand Oaks. CA. U.S.A.). 
Neuronal culture 
Neurons were prepared and cultured as described previ-
ously (Hawrot and Patterson. 1979: Wolinsky ct al.. 1985) 
with the modification noted below. Brien~. superior cervi-
cal ganglia were dissected from neonatal rats. enzymatically 
dissociated with 0.1% trypsm. and cultured in L 15-C02 me-
dium supplemented with 100 JJg/ml of transferrin. 100 ng/ 
ml of nerve growth factor. 5 JJg/ml of insulin, 16 JJg/ml of 
putrescine, 30 nM sodium seleni te. and 4 JJg/ml of aphidi-
colin. Aphidicolin was used here because 11 IS a relatively 
nontoxic antimitotic agent used to elimmatc nonneuronal 
cells (Wallace and Johnson. 1989). For ease and reproduc-
ibility, neurons were seeded 111 96-well plates (Falcon. Ox-
nard, CA. U .S.A.) at a densit~ of one ganglion per well. Half 
of the medium was changed every 36 h in an effort to ensure 
the activity of the cytokines. After 7 days. each well con-
tained approximately 3.000 cells (Wolinsky et al. . 1985) and 
J Nt!urochcm . l "of o / A'o 4 !99l 
more than 95'1. of sun" Ill!'- ct:ll' were neuron~ . lvtoJ..mcs 
were added from the ~econd da' or culture. and duplicate 
wells were prepared for each cond111on 
Preparation of RNA and eDNA 
Adult rat spinal cord RNA \\:J\ prepared b~ d1~rupuon of 
the t1ssue in 4 M guan1d1n1LII1l lh1ocyan:nc u~ing a syringe, 
and extractiOn with ac1dK phenol and chloroform (Chomc-
zynski and Sacch1. 19R7l. ·1 otal RNA from cultured neu-
rons was prepared 111 the same manner. but smaller 
amounts of matenal were used ( BelyavsJ..~ et al.. 1989). 
Briefly. 160 JJI of lys1s buffer (4 .II guanid1 nium th1ocyanate. 
25 mAl sodium citrate. pH 7.0. 100 m/11 2-mercaptoeth-
anol, and 0.5% sodium laurovl sarcos1nate) wa5 added to 
each well. The lysate was tra~sferred to I. 7-ml Eppendorf 
tubes and vortexed v1gorously to shear DNA. Ten micro-
liters of I M sodium acetate. pH 4.0. 200 JJI of water-satu-
rated phenol, and 40 Ill of chloroform were added sequen-
tially. with vigorous vortexing after each add1tion. The sam-
ples were kept at 4°C for 20 min and centrifuged at 12.000 g 
for 15 min. The water phase was transferred to a new tube 
containing 10 JJI of 3 mg/ ml of glycogen . RNA was precipi-
tated by addition of 200 JJI of ISOpropanol and stored at 
-20°C overnight. 
Spinal cord eDNA was prep<Jred as follows: 10 1-'g of total 
RNA in 6 JJI was denatured 111 16 JJI of 13 m/11 methylmer-
cury hydroxide in water for 10 m111. and 5 JJI of 75 mM 
2-mercaptoethanol in water for 5 m1n. Reverse transcrip-
tion was performed in a total volume of 50 JJI containing 50 
mMTris-HCI, pH 8.3. 75 mM KC'I. 3 mM MgCI2 • 0.5 mM 
dNTP. 0.5 1-'g of oligo dT. 40 U of RNasin. and 200 U of 
RTase for I h at 37°C. To produce eDNA from cultured 
neurons, total RNA was centrifuged at 12,000 g for 15 min. 
washed once with 70% ethanol. and dried in a Speedvac 
(Savant, Farmingdale. NY. U.S.A.). The RNA was dis-
solved directly in 10 JJI of 13 m/11 methylmercury hydroxide 
for I 0 min, and an additiOnal 2 JJI of 7 5 mM 2-mercaptoeth-
anol was added for 5 mm. Reverse transcription was per-
formed in a final volume of 20 JJI. with the buffer described 
above. and 100 U of RTase and 20 U of RNasin for I h 
at 3JOC. 
PCR 
Most of the oligonucleoudes were selected as pnmers ac-
cording to the criteria described by Lowe et al. ( 1990). For 
those genes without available genomic DNA sequences, sev-
eral distinct oligonucleotides were synthesized and tested in 
PCR pilot experiments using spinal cord eDNA as template. 
Primers that could discnminate eDNA from genomic DNA 
were selected for further study. The sequences of each pair 
of primers are given in Table I. Amplification of eDNA was 
performed in a thermal cycler (MJ Research. Watertown, 
MA, U.S.A.) with each tube containing a final volume of20 
Ill. consisting of I Ill of eDNA, I X PCR buffer. 0.5 U of Taq 
DNA polymerase, 0.25 mM dNTP. and one set of primers 
(200 nM). The following conditions were used for PCR: 
94°C for 45 s, annealing temperature (temperatures for 
each eDNA listed in Table I) for 75 s. and 7rC for 30 s. 
The numbers of cycles used to amplify each eDNA were 
chosen to allow the PC'R to proceed in a linear range. but 
with sufficient yield to be visualized by ethidium bromide 
stainmg; and the cychng profile for each gene is listed in 
Table I. The appropriate cycling profiles were determined 
empirically. Eight microhters of each PC'R sample was ana-
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lyzcd on a 2% agarose gd . . md the product~ were 'Jsuali7cd 
with cthid1um bromide st~1mng ~nd l IV lllumJnallon. 
RESULTS 
Selection of primers 
An RT-PCR assay was destgned to facilitate the 
measurement of mRNAs for neuropepudes and neu-
rotransmitter synthetic enzymes using small numbers 
of cultured neurons. Fourteen sets of oligonucleotide 
primers were made to detect mRNAs for ,13-actin, the 
neurotransmitter synthetic enzymes ChAT, 65-kDa 
glutamic acid decarboxylase (GAD65), 67-kDa glu-
tamic acid decarboxylase (GAD6 7), tyrosine hydroxy-
lase (TH), and tryptophan hydroxylase (TPH), and 
the neuropeptides calcitonin gene-related peptide 
(CGRP), CCK, dynorphin (DYN), ENK, neuropep-
tide Y (NPY), SOM, SP, and VIP. For those genes 
expected to yield more than one transcript due to al-
ternative splicing: including DYN . ENK, TPH, and 
SP (Krause et al. , 1987; Darmon et al.. 1988; Garrett 
et al., 1989), the selected primers recognize regions 
common to each transcript and generate a single PCR 
product for each of these genes; the exception is SP, 
which may have four different PCR products. There 
are two different genes encoding CGRP. and the 
primers were designed to identify one of them, 
CGRPa (Amara et al. , 1982, 1985 ). The sequences of 
primers, annealing temperatures, amplification cy-
cles, and the predicted sizes of the PCR products are 
given in Table L 
Specificity of the primers 
We first tested whether these primers specifically 
identify the mRNAs for the intended neuromodula-
tors. Total RNA was prepared from adult rat spinal 
cord and reverse-transcribed into eDNA. All cDNAs 
except actin were amplified for 35 cycles; actin was 
amplified for 20 cycles. Each set of primers (except 
those for SP) generated a single PCR product whose 
size was predicted from the known gene sequences 
(Fig. I, "+" lanes). Reverse transcription was essen-
tial for generation of these expected products, as they 
did not appear in the samples that were not treated 
with reverse transcriptase (Fig. I , " - " lanes). The 
primers for GAD65. SOM, and TH presumably also 
recognized genomic DNA and produced PCR prod-
ucts whose sizes were larger than expected in the sam-
ples not treated with reverse transcriptase (Fig. I, 
GAD65, SOM, TH, " - "lanes). This did not interfere 
with the assay, however, because these bands disap-
peared when there is competition with the proper 
templates present in the eDNA. The SP primers pro-
duced three products whose sizes (375 , 331, and 276 
bp) corresponded to the mRNAs for {3- , ")'-. and o-SP, 
respectively (Krause et al., 1987; Harmar et al., 1990). 
The assay also yielded the expected relative levels of 
these mRNAs; t'I-SP and )'-SP were more abundant 
than o-SP, whereas a-SP comprised less than I% of 
the total SP mR NAs (Carter and Krause. 1990; Har-
mar et al .. 1990) and was undetectable Ill our assay. 
We used two sets o f primers to detect GAD67 and 
GAD65, and judging from the intensity of the prod-
ucts, there was more GAD67 than GAD65 mRNA in 
the spinal cord. 
These results demonstrate that the chosen primers 
yield a specific assay for these neuromodulators. We 
sequenced three PCR products (t'l-actin, because there 
are many actin homologues, and CCK and ENK, be-
cause our findings for these two genes are novel, as 
described below). All the clones that were sequenced 
(at least three clones for each PCR product) contained 
the sequences expected for these genes. This was ex-
pected, because the annealing temperature used in the 
PCR for each set of primers was close to or above the 
predicted melting temperature in an effort to increase 
the specificity of the PCR. In addiuon, we have dem-
onstrated that these PCR products only appear when 
RT is present, that there is only one PCR product for 
each gene analyzed. and that the size of each PCR 
product is identical to that predicted from the known 
sequences. Although the PCR can generate artifacts 
when unknown sequences are cloned from ambigu-
ous primers, this type of artifact rarely occurs with 
primers that are identical to the known sequences, 
especially when the PCR is carried out under high-
stringency conditions. as in these experiments. There-
fore, the PCR products obtained here should repre-
sent products of the genes indicated. The data also 
show that the adult rat spinal cord expresses a variety 
ofneuromodulator mRNAs, albeit at different levels, 
some of which (DY::--J, GAD65) had not been readily 
identified in the spinal cord by other methods. 
CDF /LIF induces CCK and ENK in cultured 
sympathetic neurons 
To test further the applicability of the assay, we 
asked whether it can reproduce the known effects of 
CDF/LIF on cultured sympathetic neurons. It had 
been shown that CDF/LIF induces the expression of 
SP, SOM, VIP, and ChAT (Nawa et al., 1990, 1991 ). 
Sympathetic neurons were cultured in 96-well plates 
for 7 days in serum-free medium to avoid the induc-
tive effects of serum (Wolinsky and Patterson. 1985). 
Different concentrations of recombinant human 
CDF/LIF were added between days 2 and 7. Dupli-
cate samples were used for each concentration to 
compensate for an occasional failure of amplification 
(about 5%). At the end of 7 days of culture, RNA was 
extracted from each well and reverse transcribed to 
eDNA. The eDNA derived from a single well was 
used as template for 14 PCRs for each gene. in 14 
separate tubes. {3-Actin expression was used to moni-
tor the amount of RNA in each sample. The expres-
sion pattern of these neuromodulators, with and with-
out CDF/LIF, was similar to that previously reported 
(Nawa et al., 1990). CDF/LIF induced expression of 
J \ 't'llrtN. I U'm , I ol ol \ o 4. IVCJJ 
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Prcdoctcd Annealing A mplification 
Ncuromodulatoo ~c..·qul.'nl.T SIZe (bp) temp cvclcs Reference 
11-Aclln 1 C-\ TGAAGTG I GACGn GACA I CCGT :!85 5X 18 N ude! et al .. 1983 
CCT AGAAGC A r11 G< ( ;(; lGCACGA T G 
CG RP TTCl GAAGTI C1 CCCCTTI < ·c 16'i 58 35 A mara ct al .. 198:! 
GC AT AT AGTTCTGC ACC AG I ( ,( 
CCK G ACTCCGCAT CCGAAGAT 366 50 35 D eschenes ct aL. 1985 
CTACGATGGG1 ATTCG1 A 
ChAT GCTTACTACAGGCT1TAC' 338 50 30 Hahn et al . 1992 
GACAA ACCGG ITGCTCA1 
DYN A TC AAC'C'CCCTGA Tn GCl Cl 368 60 33 Dougla,; ct a!., 1989 
GCCTGTTTTC'TC' AAG TC'Cl CC 
ENK A T C AACTTCCTGGC A TGC 429 50 28 Rosen et al.. 1984 
GCT C'GT GCTGTCTTCATC 
G A D65 GC'TCTGGC'TTTT GGTC'CTTCG 220 58 40 Erlander ct al., 1991 
TTTTGGTC'ACAGGTGCAGGCG 
GAD 67 CTGCCAATACCAAT AT GTTCAC 297 58 35 Wybors~1 et aL. 1990 
TTG T CAGTTCC'AAAGCCAAGCG 
N PY GCTAGG T AACAAACGA ATGGGG 288 58 22 Larhammar et al. . 1987 
CACATGGAAGGGTCTTCAAGC 
SOM CCAGACTCCGT CAGTTTCTGC' 238 58 28 M ontm1ny et aL. 1984 
AGTTCTTGCAGCCAGCTTTGC 
SP ATGAAAAT CCTCGTGGCG o ~ 32 1 ./l=375 58 27 Caner and Krause. 1990 
GTAGTTCTGC'AT TGC'GC1 
TPH GATGCAAAGGAGA AGAT G 
T AAGCAGGTG ACAGAAAT 




SP, YIP, ChAT, and SOM in a dose-dependent man-
ner (Fig. 2). In addition, CDF/ LIF induced expression 
ofCCK and ENK. These data clearly illustrate that by 
this RT-PCR assay we can reproduce previous results. 
as well as provide the sensitivity to uncover new find-
ings. 
FIG. 1. Primers amplify cDNA-<Jenved, but not genomic, DNA 
templates. Total RNA was prepared from adult rat spinal cord and 
either convened to eDNA with reverse transcnptase (" +" lanes) 
or not treated with reverse transcnptase ("-" lanes). All samples 
were amplified lor 35 cycles on the PCR, except actin, whoch was 
amplifoed for 20 cycles The samples were loaded on ascending 
order of expected sozes. based on the known gene sequences. as 
listed in Table 1. A 1-kb DNA marker was used as DNA molecular 
weoght standard (" M " lanes) and the measured s1zes are. from 
bottom to top. 75, 134. 154. 201 . 220. 298.344. 396.517/506. 
1.018. 1,635, 2.036 bp. 
J Ncurodwm. I 'o/ 6 1 .\ (, 4 I VCJ.l 
.., 33 1.6= 276 
410 50 3 1 Darmon et al .. 1988 
41 8 58 24 G nma et al.. 1985 
2 16 58 28 N oshoz.av.a ct aL. 1985 
The concentrations of CDF/ LIF needed to induce 
various mRNAs to maximal levels varied. The signals 
for SP, YIP, and ENK reached plateau at 0.4 ng/ml of 
CDF/LIF, whereas more than 1.6 ng/ml was needed 
to induce the expression of ChAT, SOM. and CCK 
full y. It may be that different genes are induced by 
different transcription factors, which are turned on at 
different concentrations ofCDF/ LIF (e.g., Lord et al. , 
1991 ; Yamamori. 1991; lp et al. , 1992). 
The assay was further used to determine the effect 
of CDF/LIF on other neuromodulators found previ-
ously to be expressed by sympathetic neurons (Sah 
and Matsumoto, 1987; Nawa and Sah, 1990; Van-
denbergh et al., 1991 ). In the absence of CDF/LIF, 
these neurons delectably expressed mRNAs for the 
transmitter/synthetic enzymes TH, TPH, and 
GAD67, as well as the neuropeptides DYN, NPY, 
and CGRP (Fig. 2). GAD65 was undetectable, even 
after 40 cycles of amplification (data not shown). Ad-
dition of CDF/LIF did not increase expression of 
these genes. The apparent increase in expression of 
GAD67 by CDF/LIF (Fig. 2) was not reproducible. 
We were unable to determine whether CDF/ LIF de-
creased the expression of these genes (TH, NPY, 
CGRP, TPH, DYN) because the {3-actin control also 
decreased at high concentrations of CDF/ LIF. Be-
cause this type of deleterious effect had not been 
found with purified heart cell CDF/LIF (Fukada, 
1985), the apparent toxicity may be due to Esche-
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FIG. 2. CDF/LIF onduces expressoon of SP. VIP. ChAT, SOM, 
CCK. and ENK, but not TH. NPY, CGRP. TPH. DYN, or GAD67 on 
cultured sympathetoc neurons. DoNerent concentratoons of CDF/ 
LIF (nanograms per milliliter) were added to cultured sympathet•c 
neurons for 6 days and the AT -PCR assay was used to monitor a 
vanety of mRNAs. Duplicate samples were run at each concen-
tratoon Acton was used as control to monotor the amount of 
mRNA on the sample. Some lanes yoeld no products due to faolure 
of ampllfocatoon. The 1-kb DNA marker ("M" lane) was used as on 
Fog 1 
richia coli-derived products in the recombinant pro-
tein preparation. 
CNTF induces the same neuromodulators as 
COF/LIF 
Another cytokine that has been shown to induce 
the expression of several neuromodulators is CNTF 
(Saadat et al., 1989; Rao et al., 1992a). CNTF is pre-
dicted to have a structure similar to that of CDF/LIF 
(Bazan, 1991; Rose and Bruce, 1991 ). In addition, 
CNTF shares receptor subunits and signal transduc-
tion pathways with CDF/LIF (lp et al., 1992). When 
added to the sympathetic neuronal cultures and ana-
lyzed by RT-PCR assay, CNTF induced the same pat-
tern of neuromodulators as CDF/LIF (Fig. 3). The 
induction of SP, VIP, ChAT. SOM, CCK. and ENK 
mRNAs was clear. As with CDF/LIF, a higher con-
centration of CNTF was required to induce SOM, 
ChAT, and CCK. The induction of SP, VIP, ChAT, 
and SOM by CNTF had been shown previously by 
other methods (Saadat et al., 1989; Rao et al., 1992a). 
CNTF had no detectable inductive effects on TH. 
NPY. CGRP, TPH, DYN, or GAD67 (data not 
shown). Although higher concentrations ofCNTF ap-
peared to be required for induction of neuromodula-
tors in Fig. 3. such concentration differences between 
the effects ofCNTF and CDF/LIF were not reproduc-
ible. The decrease of {3-actin with increasing CNTF 
may indicate. hov.c' cr. that tO\ICtt\ r~ assoCiated wtth 
the recombinant protctn preparation 
DISCl 1SSIO'-' 
We describe a method. based on In -PCR. for de-
tecting mRNAs for a ,·,met~ oftran~mrtters and neu-
ropeptides present at low l evel~ on primary neuronal 
cu ltures. Specific sets of primer~ were designed for 14 
different genes. When tested in RT-PCR using adult 
spinal cord RNA, thesc pr·imers amplify eDNA even 
in the presence of genomic DNA. and single PCR 
products are generated that have the sizes predicted 
from the known sequences of the genes (except for SP, 
which yielded three products of expected sizes). This 
demonstrates that genomic DNA does not interfere 
with the assay even though it may contaminate the 
samples. 
Sympathetic neurons have been used to study neu-
ronal phenotypic chotec and to identify neuronal dif-
ferentiation factors (Patterson. 1978, 1992). Using the 
RT-PCR method. we demonstrate that cultured sym-
pathetic neurons ha' e the capacity to express CGRP, 
CCK, ChAT. DYN. ENK. GAD67. NPY. SOM, SP, 
TPH, TH. and VIP. The expression of this variety of 
genes makes sympathetic neurons a good choice for a 
responder cell to test the eflccts of candidate neuronal 
differentiation factors. When CDF/LIF and CNTF 
are applied to sympathetic neurons. they induce ex-
pression of mRNAs for CCK. ChAT. ENK. SOM, SP, 
and VIP in a verv stmi lar manner. The finding that 
CCK and ENK a~e induced bv CDF/LIF and CNTF 
had not been reported previo-usly. and suggests that 
these cytokines may be responsible for the induction 
of CCK and ENK b~ heart cell conditioned medium 
(Nawa and Sah. 1990). 
Rao et at. ( 1992a) did not observe induction of leu-
en kephalin by CNTF using a radioimmunoassay for 
M l 0 I 0.1 10.41 1.616.4125 11001 
Actin 
SP 
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FIG. 3. CNTF onduces the same set of neuromodulators as does 
CDF/LIF on cultured sympathetoc neurons. Vanous concentra-
tions of CNTF (nanograms per molllllter) were added to cultured 
sympathetoc neurons for 6 days and the RT-PCR assay was used 
to monttor the expressoon of neuromodulators as on Fog. 2 . 
.I fto t•uro< lwm l 'ol ()J \'o 4. /99 3 
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the ncuropeptide. This discrepancy with our results 
may be due to a difference in sensillvity of the assays 
or to induction ofENK mRNA but not ENK peptide. 
Such a differential regulation of mRNA and protein 
has been shown previously. For example. nonneuro-
nal cells induce SOM mRNA but not SOM peptide in 
cultured sympathetic neurons (Spiegel eta\., 1990). In 
addition, ENK mRNA is induced in the adrenal me-
dulla when it is placed in culture (Zhu eta\., 1992). It 
may be interesting to determine whether CDF/LIF or 
CNTF is responsible for this induction. 
The concentration ofCDF/LIF and CNTF needed 
for full induction ofSP, ENK, and VIP was different 
from that required for full induction of ChAT, SOM, 
and CCK. This suggests that these genes are regulated 
by different signal transduction pathways. It has been 
shown that CDF/LIF and CNTF induce the expres-
sion of several early genes, including c-jun, junE. 
junD. c-fos, and tis] 1 (Lord et al.. 1991; Yamamori, 
1991; lp et al., 1992). The concentration dependence 
of the induction of these early genes has not been re-
ported, however. 
The present results further characterize the effects 
ofCDF/LIF and CNTF on cultured sympathetic neu-
rons. These data are consistent with indications that 
these cytokines can share receptor subunits and signal 
transduction pathways (lp et a\., 1992), as predicted 
by Bazan ( 1991 ). The emerging picture of a family of 
neuropoietic cytokines that have redundant effects on 
the nervous system is consistent with similar findings 
on the control of hematopoietic phenotypes (Nawa et 
a\. , 1990; Patterson and Nawa, !993). 
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Neuropoietic cytokines and activin A differentially regulate the 
phenotype of cultured sympathetic neurons 
MING-JI FANN AND PAUL H . PAlTERSON 
Biology D1V1S 10n, California lnsutute of Tec hnology, Pasadena, CA 9112~ 
Communicated by Norman Davidson . Augus t 3/ , /993 (recetved for re ••ie ><· July 2 . / 993 ) 
ABSTRACT A number of cytokines sharing limited se-
quence homology have been grouped as a family because of 
partially overlapping biological activities, receptor subunit 
promiscuity, and the prediction of a shared secondary struc-
ture. Since several of these cytokines regulate gene expression 
and cell number in the nervous and hematopoietic systems, this 
specific group is tenned the neuropoietic cytokine family. Using 
a reverse transcription-polymerase chain reaction-based assay 
system for monitoring the expression of multiple phenotypic 
markers in cultured sympathetic neurons, we present further 
evidence that, in addition to cholinergic differentiation factor/ 
leukemia inhibitory factor and ciliary neurotrophic factor, 
oncostatin M, growth promoting activity, interleukin 6, and 
interleukin 11 belong in this family. In addition, one member 
of the transfonning growth factor fJ superfamily, activin A, 
shares a selective overlap with the neuropoietic family in the 
spectrum of neuropeptides that it induces in sympathetic 
neurons. The particular neuropeptides induced by activin A, 
however, demonstrate that the activity of this cytokine is 
distinct from that of the neuropoietic family. Twenty-six other 
cytokines and growth factors were without detectable activity 
in this assay. 
Diffusible proteins can regulate neural development at a 
number of stages, from the initial proliferation and differen-
tiation of progenitor cells, through the outgrowth of pro-
cesses and formation of synapses, to the rearrangement of 
connections in postnatal life (1). Two of the families of 
proteins involved in these events include the neurotrophins 
and the neuropoietic cytokines. The prototype of the former 
group is nerve growth factor (NGF), and subsequent family 
members were cloned by utilizing the extensive homology 
between NGF and the second neurotrophin identified, brain· 
derived neurotrophic factor. In contrast, the neuropoietic 
family is emerging not through strong homologies among 
cytokine sequences, but rather by shared biological activities 
and predicted secondary structures (2 , 3). Subsequent studies 
on the receptors for the neuropoietic cytokines have revealed 
not only structural homology among the receptors but the 
sharing of a common receptor transducing subunit and similar 
signal-transducing pathways (4-8). 
Inaugural members of the neuropoietic family include a 
protein we termed the cholinergic differentiation factor 
(CDF; refs. 9-11), also widely known as leukemia inhibitory 
factor (LIF; ref. 12), and ciliary neurotrophic factor (CNTF; 
refs. 13-15). These two proteins display identical proftles of 
activity in the regulation of neuropeptide expression in cul-
tured sympathetic neurons (16, 17) and in the support of 
motor neuron survival (18, 19). In addition, Bazan (2) pre-
dicted that CDF / LIF and CNTF would share a similar 
secondary structure with interleukin (IL)-6, oncostatin M 
(OSM) , and granulocyte colony-s timulating factor (G-CSF). 
Similar predictions were made by Rose and Bruce (20) . While 
The publication costs of this article were defrayed in part by page charge 
payment. This article must therefore be hereby marked "advertisement'" 
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it was known that CDF / LIF and IL-6 ehccted many of the 
same responses in nonneural cells (21), the linkage with OSM 
was not previously suspected. Further evidence for a close 
relationship between these proteins is the finding that OSM 
can displace CDF/ LIF from its binding sites on Ml cells (22). 
Moreover, OSM was recently found to induce the same 
neuropeptide in a neuroblastoma line as CDF/ LIF (23). 
Another candidate for membership in this family is IL-11, a 
cytokine that phosphorylates the same gp130 receptor sub-
unit as do CDF/ LIF. CNTF. and IL-6 (5. 24). Recently , 
growth-promoting activity (GPA), a protein that shares 
trophic activity for ciliary neurons with CNTF, was cloned 
from chicken and found to have a limited sequence homology 
with mammalian CNTF (25). Finally. extracts of rat foot pads 
(which contain sweat glands, the target of cholinergic sym-
pathetic neurons) were found to contain a protein , termed the 
sweat gland factor (SGF). that exhibits both CDF/ LIF and 
CNTF activities and is similar to, but distinct from, CNTF 
(26, 27). SGF has not as yet been sequenced. All of these 
proteins are therefore candidates for membership in the 
neuropoietic cytokine family. 
Other cytokines may be involved in the development of the 
nervous system. IL-3 acts as a trophic factor for central 
cholinergic neurons (28), and IL-5, -7, -9, and -11 regulate 
differentiation of murine hippocampal progenitor cells (29). 
IL-l and tumor necrosis factor a (TN Fa), two inflammatory 
cytokines released after injury, can induce NGF and CDF/ 
LIF, which in turn have effects on neuronal survival and gene 
expression (30-32). Activin A, a member of the transforming 
growth factor f3 (TGF/3) superfamily, stimulates expression 
of the neuropeptide somatostatin in cultured ciliary ganglion 
neurons (33). Accordingly, these cytokines are candidate 
neuronal differentiation factors . Nonetheless, there has been 
no systematic analysis of the effects of these cytokines on 
neuronal phenotype. 
We have designed a reverse transcription (RT)-PCR assay 
to analyze the effects of soluble factors on the expression of 
neuropeptides and neurotransmitter synthesizing enzymes in 
cultured sympathetic neurons. In this assay, CDF/ LIF and 
CNTF induce an identical set of neuropeptide and neuro-
transmitter enzyme mRNAs (34). We here present the results 
of testing the effects of 33 different recombinant cytokines 
and growth factors on neuronal gene expression. These 
Abbreviations: CCK, cholecystokinin ; CDF/LIF, cholinergic dif-
ferentiation factor/ leukemia inhibitory factor; CGRP, calcitonin 
gene-related peptide; ChAT, choline acetyltransferase; CNTF, cili-
ary neurotrophic factor: DYN , dynorphin; ENK, enkephalin; FGF. 
fibroblast growth factor; GAD65. 65-kDa glutamic acid decarboxy-
lase: GAD67. 67-kDa glutamic acid decarboxylase: G-CSF, granu-
locyte colony-stimulating factor; GPA. growth-promoting activity; 
GROa. growth-related cytokine a ; IL. interleukin ; M-CSF. macro-
phage colony-stimulating factor; MIP!a, macrophage inOammatory 
protein Ia; NGF, nerve growth factor; NPY . neuropeptide Y; OSM, 
oncostatin M; rh-. recombinant human : RT, reverse transcription: 
SGF, sweat gland factor; SOM , somatostatin ; SP, substance P: 
TGFa and -{3. transforming growth factor a and {3 ; TH. tyrosine 
hydroxylase: TNFa, tumor necrosis factor a : TPH , tryptophan 
hydroxylase ; VIP, vasoact1ve intestinal polypeptide . 
37 
44 Neurobiology: Fann and Pa ttc r, nn 
results support the hypothesis that GPA and OSM belong 111 
the neuropoietic family. In addit1on . weak activitie~ of IL-6 
and IL-11 can also be detected 111 thl\ as\a}. The pattern of 
neuronal gene expression induced by acu vm A . however, 
sets it apart from this family . 
MATERIALS AND METHODS 
Animals and Reagents. Neonatal Sprague-Dawley rats 
were purchased from Simonsen Laboratories (Gilroy, CA). 
Most of the tissue culture reagent~ . Superscript reverse 
transcriptase II , and the 1-kb DNA marker were purchased 
from GIBCO/BRL. NGF, glycogen. dATP. dCTP. dGTP, 
dTTP, acidic fibroblast growth factor (FGF) and basic FGF 
were purchased from Boehringer Mannheim. RNase inhibi-
tor (RNasin) and Taq DNA polymerase were purchased from 
Promega. Oligo(dT) was obtained from Pharmacia. Oligonu-
cleotide primers were synthesized in the Biopolymer Syn-
thesis and Analysis Resource Center at Caltech. The recom-
binant proteins murine IL-l, murine TNF-a. human activin 
A, human growth-related cytokine a (GROa). and rat CNTF 
were gifts from Genentech . Chick GPA was kindly provided 
by T. Finn and Rae Nishi of Oregon Health Sciences Uni-
versity (Portland). Human recombinant activin A was also 
obtained from Jim Smith at the National institute for Medical 
Research (London). Human macrophage inflammatory pro-
tein Ia (MIPla) was provided by Mary Freshney and Gerry 
Graham at the Beatson Institute for Cancer Research (Glas-
gow, U.K.). The recombinant proteins murine IL-3. -4 , -6, -7, 
and -9, human IL-8, and macrophage colony stimulating 
factor (M-CSF) were purchased from R & D Systems. The 
recombinant protein human IL-10 was supplied from Gen-
zyme. The recombinant protein human IL-11 was a gift from 
Yu-Chung Yang at Indiana University. The recombinant 
protein murine IL-12 was provided by Stanley Wolf from 
Genetics Institute (Cambridge, MA). The recombinant pro-
tein human OSM was provided by David Gearing at Im-
munex. Other cytokines and growth factors used in this study 
were recombinant human (rh) proteins provided by James 
Miller and colleagues at Amgen. All other reagents were 
purchased from Sigma. 
Neuronal Culture. Dissociated sympathetic neurons were 
prepared and cultured in serum-free medium as described 
previously (34-36). For reproducibility, neurons were seeded 
in 96-well plates (Falcon), at a density of one ganglion per 
well. Cultures were maintained for 7 days, and half of the 
medium was changed every 36 hr in an effort to ensure that 
cytok.ines maintained activity. The antimitotic agent aphidi-
colin was added to the cultures at the concentration of 4 
~/ml, effectively eliminating nonneuronal cells. After 7 
days, each well contained approximately 3000 neurons, and 
more than 95% of the surviving cells were neurons, as judged 
by phase-contrast microscopy (36). Cytokines and growth 
factors were added from the second day of culture, and 
duplicate wells were prepared for each condition. All results 
reported here were reproduced in at least two separate 
neuronal platings. 
Preparation of RNA and eDNA. Total RNA preparation and 
eDNA synthesis from cultured neurons were as described 
previously (34). Briefly, 160 JL) of lysis buffer was added to 
each well. The lysate was transferred to a 1.7-ml Eppendorf 
tube and swirled vigorously to shear DNA, and then one 
round of acidic phenol/chloroform extraction was performed 
to deplete DNA and proteins. RNA was coprecipitated with 
30 ~ of glycogen in a 50% isopropyl alcohol solution and 
stored at - 2o•c overnight. 
To produce eDNA from the cultured neurons, the total 
RNA was centrifuged, dried, and directly dissolved in 10 JL) 
of 13 mM methylmercury hydroxide for 10 min , and an 
additional 2 JL1 of 75 mM 2-mercaptoethanol was added for 5 
Proc. N at/. A ca d. Sc1 USA <J I (1994) 
min. Oligo(dT)-primed RT was done in a final volume of 20 
JLI, containing the RT buffer (34). 100 unib of reverse 
transcriptase, and 20 units of RNasin , for 1 hr at 37•c . 
PCR. The sequences of the primers and conditions used in 
the PCR for each neuronal gene analyzed were described in 
a previous report (34). Amplification of eDNA was performed 
in a thermal cycler (MJ Research, Watertown, MA). Each 
tube contained a final volume of 20 JLI , consisting of 1 JLl of 
eDNA, 1 x PCR buffer (Promega), 0 .5 unit of Taq DNA 
polymerase, 0.25 mM dNTP, and one set of primers (200 nM). 
After the reaction , 8 JLI of each PCR sample was analyzed on 
a 2% agarose gel, and the products were visualized after 
ethidium bromide staining and UV illumination. The appro-
priate amplification cycle schedule for each neuropeptide 
gene was determined empirically, to allow a minimal, yet 
detectable, signal for control samples (neurons grown with-
out cytokines or growth factors). Cytokines were deemed to 
have regulatory effects on specific genes if the intensities of 
the PCR products were about 3-fold different from those of 
negative controls, as judged by eye. 
RESULTS 
Screening of 33 Cytokines and Growth Factors for Effects on 
Neuronal Gene Expression. In the first screen for effects of 
cytok.ines and growth factors on neuronal phenotype, two 
concentrations (10 ng/ml and 100 ng/ml) of each recombinant 
protein were applied to neonatal rat sympathetic neurons in 
culture for 6 days. The expression pattern of different neu-
romodulators in the presence of cytok.ines and growth factors 
was elucidated by the RT-PCR assay and the results are 
summarized in Table 1. Twenty-six factors showed no effect 
on the intensity of the PCR products for any of the six genes 
analyzed, in at least two independent experiments; these 
factors were not analyzed further. In addition to reporting our 
findings with CDF/LIF and CNTF, we report here in detail 
for the first time the effects of GPA, OSM, IL-6, IL-11, and 
activin A on neuronal gene expression. Some of the inductive 
effects of CDF/LIF, CNTF, and OSM have been demon-
strated previously (16, 17, 23, 34, 37). 
GPA Induces the Same Set of Neuropeptides and Neuro-
transmitter Synthetic Enzymes as CNTF. GPA was purified 
from chick and has the same ciliary neurotrophic activity as 
mammalian CNTF. Moreover, the amino acid sequence of 
GPA shows a 50% identity to the sequences for human, rat, 
and rabbit CNTF (25). In contrast to CNTF, however, GPA 
has been shown to be secreted from cells in a transient 
transfection experiment (25). We tested whether GPA has the 
same effects as CNTF on cultured sympathetic neurons, and 
the results are illustrated in Fig. 1. The ,8-actin band was used 
to monitor the amount of mRNA present in each sample, and 
duplicate samples were prepared for each condition. GPA 
induces mRNAs for the neuropeptides substance P (SP), 
enkephalin (ENK), vasoactive intestinal polypeptide (VIP), 
cholecystokinin (CCK), and somatostatin (SOM), as weU as 
the enzyme for synthesizing acetylcholine, choline acetyl-
transferase (ChAT), in a dose-dependent manner. This pat-
tern of neuropeptide induction is very similar to that of CNTF 
and CDF /LIF. We also analyzed expression of the mRNAs 
for the enzymes synthesizing -y-aminobutyric acid (glutamic 
acid decarboxylase; GAD65 and GAD67 for the 65- and 
67-kDa forms), the enzyme for synthesizing catecholamines 
(tyrosine hydroxylase; TH), the enzyme for synthesizing 
serotonin (tryptophan hydroxylase; TPH), and the neuropep-
tides calcitonin gene-related peptide (CGRP), dynorphin 
(DYN), and neuropeptide Y (NPY). As with CNTF, GPA has 
no detectable inductive effect on these genes at the mRNA 
level (data not shown) . This identity in the expression pat-
terns of 13 neuropeptide and neurotransmitter mRNAs 
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Table l. Regulation of gene expressoon on sympathctoc neuron' 
Cytokines 
Neuropoiet1c 






IL-lo, -2. -3, -4, -5 , -7. -8. -9, -10, -12. 
IFN-y, GM-CSF. M-CSF. EPO. 
TGFo, TGF/3, EGF, IGF-1 , TNFo. 
SCF, MIP!o, GROo, PDGF. acidic 



























A + indicates that there is induction effect ; a - indicates that there is no induction effect ; ND, not determined. Cytok.ines not previously 
defined: IFN-y. interferon -y; EPO. erythropooeton; TGFo and -{3, transforming growth factor o and /3: EGF, epidermal growth factor; IGF-1. 
insulin-like growth factor I; SCF. stem cell factor ; PDGF, platelet-denved growth factor. Neuropeptides and enzymes in column heads are 
defined in the text. 
strengthens the idea that GPA and CNTF share many bio-
logical activities. 
OSM, IL-6, and IL-11 Have Activity in the Sympathetic 
Neuron Assay. OSM and CDF/LIF have the same biological 
activities in several assay systems, including triggering dif-
ferentiation of Ml leukemia cells and the induction of the 
acute phase response in hepatocytes (38, 39). Recently, 
Gearing and colleague (22) provided evidence that OSM 
binds to the CDF/LIF receptor with high affinity. To test the 
effects of OSM on sympathetic neurons, various concentra-
tions of human OSM were applied and the expression of 
neuronal genes was analyzed. For comparison, CDF/LIF at 
1.6 ng/ ml was included in sister cultures. The data in Fig. 2 
illustrate that OSM induces mRNAs for SP, ENK, ChAT, 
and CCK, but only at concentrations (> 25 ng/ml) higher than 
required for similar inductive effects by CDF/LIF. OSM 
induces a low level of mRNA for SOM, even at 400 ng/ml. 
It is possible that this quantitative difference is due to the 
species difference between OSM (human) and the target 
neurons (rat). Reduced responsiveness of rat cells to OSM 
was also demonstrated in an acute phase protein assay (39). 
Like GPA, OSM does not induce the expression of the 
mRNAs for GAD65, GAD67 , TH , TPH, CGRP, DYN, and 
NPY (data not shown). 
As outlined in the introduction, there are results raising the 
possibility that several other cytokines may belong to the 
neuropoietic family. These include G-CSF, IL-6, and IL-11. 
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FIG. I. Rat CNTF and chicken GPA induce mRNAs for SP, 
ENK. VIP, ChAT, CCK, and SOM with a similar dose dependency. 
Various concentrations (ng/ml) of rat CNTF and chicken GPA were 
added to cultured sympathetic neurons from day 2to day 7. Duplicate 
samples were run for each concentration. The relative abundance of 
each mRNA was analyzed by RT-PCR. The expression of ,6-actin 
was used to monitor the amount of RNA in each sample. The DNA 
molecular weight standard (m lane) is a 1-kb DNA marker. 
a long with CDF / LIF for comparison, and the results are 
illustrated in Fig. 3. G-CSF has no detectable activity on the 
expression of any of the genes analyzed . IL-6 and IL-11 , in 
contrast , induce preprotachykinin mRNA (which produces 
the SP neuropeptide) . This effect is weak and is observed 
only at concentrations of > 100 ng/ ml. Among the several 
genes influenced by CDF / LIF and CNTF, SP is the one that 
displays the most striking response(> 100-fold increase; ref. 
16). Therefore, rather than displaying more specificity than 
CDF/LIF and CNTF, it could be that IL-6and IL-11 are such 
weak inducers that only an increase in SP can be observed. 
Activin A Induces a Different Set of Neuronal ~oes. Activin 
A is a member of the TGF/3 superfamily and has effects on 
erythroid differentiation , embryonic mesoderm induction 
and axis formation , and sexual development (40). Although 
this protein does not belong in the neuropoietic cytokine 
family on the basis of structure, it does have effects on 
neuronal gene expression. Since it was recently demon-
strated that activin A can induce SOM in ciliary ganglion 
neurons (33), it was of interest to determine whether activin 
A has similar effects on sympathetic neurons. In fact, activin 
A elicits an induction pattern of mRNAs for neuropeptides 
and neurotransmitter synthetic enzymes that is distinct from 
that of CNTF and CDF / LIF. As illustrated in Fig. 4, CDF / 
LIF induces mRNAs for SP, ENK, and VIP but does not alter 
the expression of CGRP and DYN mRNAs. Activin A, in 
contrast, does not alter the expression of SP, ENK, and VIP 
mRNAs, even at the concentration of 400 ng/ml, but it does 
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FIG. 2. OSM induces mRNAs for SP, ENK, ChAT, CCK, and 
SOM, but only at high concentrations. Various concentrattons 
(ng/ml) of rhOSM, or rhCDF/LIF at 1.6 ng/ml, were added to 
cultured sympathetic neurons from day 2 to day 7 and RT-PCR was 
used to monitor mRN A expression of neuropeptides and transmitter 
biosynthetic enzymes. Duplicate samples were prepared for each 
condition. Induction of mRNAs for SP and ENK occurs at 25 ng/ml. 
At 100 ng/ ml, rhOSM begins to induce mRNAs for ChAT and CCK. 
Induction of SOM was just visible at 400 ng/ ml. 
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FIG. 3. Hogh concentrations of tL-6 and IL-t I induce expression 
of mRNA for SP, while G-CSF ha' no effect on the neuronal genes 
tested. Various concentrat ions (ng / mll of rhiL-11, rhG-CSF, recom-
binant murine IL-6, or rhCDF/ LIF at 1.6 ng/ ml were added to 
neuronal cultures and the effects were analyzed by RT-PCR. Dupli-
cate samples were prepared for each condotion . IL-6 and IL-l! begm 
to show induction of SPat 100 ng/ ml. but they do not induce other 
neuromodulators. 
Moreover, while CDF / LIF down-regulates the expression of 
mRNA forTH and N PY, activin A induces higher levels of 
NPY mRNA. while TH mRNA levels appear to be unaltered. 
Activin A and C DF / LIF do have some similarities in action: 
both induce C hAT, SOM. and CCK mRNAs, and both have 
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FIG. 4 . Recombinant human acuvin A induces a novel set of 
neuronal genes; this induction is not blocked by recombinant human 
inhibin A and is additive to the effects of CDF/LIF. rhCDF/LIF at 
1.6 ng/ml or actovin A at various concentrations (ng/ ml) was applied 
to neurons and the effects were analyzed by RT-PCR. For the 
blocking experiment, activin A at 25 ng/ ml and inhibin A at 200 ng/ml 
were added to the cultures and the results are shown in lane b. The 
effects of activm A alone at 25 ng/ ml are shown in lane a. and inhibin 
A alone at 200 ng/ ml in lane c . To observe additive effects. CDF/LIF 
at 1.6 ng/ ml and activin A at 25 ng/ ml were added together (lane d). 
Duplicate samrles were prepared for each condition. Although 
inhibin A inh1bits NPY inductoon b\ activin A 111 thi< set of samples. 
this result was not observed con~ 1 ~ tentl y . and no other inhibitory 
effect s were ~een 
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·1 wo J'IOtt:lll'> , 111h1bon and loll"tat in . mhtbtt the action of 
ac11v on A We tc,tcu one of them. tnl11bin A. at the concen-
tratiOn 1200 ng/ ml) that was shown previously to mh1b1t 
induction of erythroid differentiatiOn by activin A at 25 ng/ ml 
(33) . In the sympathetiC neuron a~say inhibin has no effect by 
itself on the neuronal genes tested (Fig . 4, lane c). nor does 
11 block the cffecb of activtn A when these two proteins are 
aducd together (fig. 4. lane b). This lack of effect sugges ts 
that these neurons have the type of activin A receptor that 
does not recognize mhibin A. When activin A and CDF /LIF 
arc addcu together 1n the assay. each at a concentration 
,ufficicnt to generate maximal inductive effects in this assay, 
additive effects arc observed (Fig. 4. lane d). This implies that 
activin A and CDF / LI Fuse different mechanisms to regulate 
neuronal gene expre ssion. 
DISCUSSION 
The utihty of an RT-PCR-based assay for screening factors 
that may affect neuronal gene expression is borne out by the 
present results. Thirly-three cytokines and growth factors 
were tested for their effects on the expression of a variety of 
neuropeptides and transmitter-synthesizing enzymes that are 
known to be present in the peripheral nervous sys tem. Active 
factors can be quickly identified. and dose-response exper-
iments a llow a qualitative assessment of which genes respond 
to each factor. As illustrated by the results presented here, 
assays of a smaller subset of neuronal genes could have led 
to conclusions entirely different from those we derive from 
the larger data set. Although this method is qualitative, 
comparison of dose-response results obtained with known 
cytokines a llows an accurate analysis of the effects of novel 
factors . 
As summanzed in Table 1, most of the factors tested did 
not alter the expression of phenotypic markers in cultured 
sympathetic neurons. We cannot rule out, however, the 
possibility that some of these cytokines might have been 
active had we been able to screen the recombinant rat 
proteins. Further studies using neurons and cytokines de-
rived from the same species are necessary to clarify this 
uncer1ainty. Indeed, Mehler and colleagues (29) have pro-
vided evidence that IL-5, -7, -9, and -11 are survival and/or 
differentiation factors for murine hippocampal progenitor 
neurons. Another example is FGF. Both acidic FGF and 
basic FG F induce the c holinergic phenotype in cultured chick 
sympathetic neurons (41), but we were not able to observe 
an y c hange of expression in rat sympathetic neurons in 
several trials. Other differences in responsiveness to factors 
have been observed between rat and chicken sympathetic 
neurons (e.g., ref. 42). 
CNTF was identified and cloned from human , rat, and 
rabbit by its ability to suppor1 the survival of ciliary neurons 
in vitro. and later it was also found to maintain the survival 
of motor neurons. It does not contain a s ignal peptide for 
secretion. however, a nd it is not detected in the medium of 
transfected cells (14. 15). Moreover, CNTF is not found in 
tissue fluids or extracellular matrix preparations, except after 
axonal injury (43). A protein with CNTF-like activity (SGF) 
is found in the soluble fraction of sweat gland homogenates, 
raising the possibility that there exists a secretable CNTF 
homologue (26. 27). This idea is supporled by the finding that 
the chick expresses a secretable protein that displays 50% 
amino acid sequence identity with CNTF (25). Our laboratory 
has recently cloned a par1ial eDNA for a different CNTF 
sequence homologue from chicken , however, and this mol-
ecule appears to be the chicken version of mammalian CNTF 
(44) . Therefore. chicken GPA is also like ly to be a family 
member. The present finding that GPA possesses an activity 
on sympathetic neurons identical to that of CNTF and 
CDF / LIF further solidifies the position ofGPA in this family . 
NeurobiOlogy: !-'ann and l'allcr,on 
The present result ~ abo provodc further w pport for OSM 
a~ a neuropooetic cytokine. Although OS M \how' only a 
modes t sequence homology with C DF/ LIF . ot can dosplacc 
the latter from its receptor on Ml cell\. and if this os also the 
case for the sympathetic neuron ~. the m.:c hanism for how 
these two cytokines can regulate the same set of neuronal 
genes is straightforward. We provode evodence that lL-6 and 
IL -l! weakly induce expression of SP. and not the other 
genes tested . Since it appears that IL-6. IL- l I. CNTF, 
CDF / LIF, and OSM usc the same receptor subunit a s a 
signal transducer, gpl30. the relatovel y weak effccb observed 
here for IL-6 and IL- l I may ondocatc very low levels of the 
hgand-binding subunits for the Iau er two cytokoncs on sym-
pathetic neurons. 
The observation that activin A induces a dosunctove subset 
of neuronal genes is important for two reasons. First, it 
demonstrates that the various neuropeptide genes assayed 
can, in fact, be regulated independentl y of each other. That 
is,the observations that CCK, ENK , SP, VIP, and ChAT are 
all induced together by CDF/LIF, CNTF. GPA, and OSM is 
not simply due to a mandatory coordonate regulation of these 
neuropeptide genes . The activin A result s thus serve to 
further link the neuropoietic group together. The lack of 
induction of SP by activin A is partocularly striking, given the 
extraordinarily strong induction of thos neuropeptide by all of 
the neuropoietic cytokines. The second poont of interest in 
the activin A findings is that the partocular se t of neuropep-
tides induced by this factor closely resembles the neuropep-
tide phenotype of the cholinergic sympathetic neurons that 
innervate the sweat gland in the rat foot pad . The presence of 
CGRP induction and the absence of SP induction are impor-
tant because cholinergic sympathetic neurons express 
CGRP, but not SP, in rats (45). On this basis. activin A is a 
legitimate candidate, along with SGF, for the target -derived 
neuronal differentiation factor that induces sympathetic neu-
rons innervating sweat glands to become cholinergic. It will 
therefore be of interest to determine if activin A is expressed 
in the sweat glands during normal development. 
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CHAPTER 4. Regulation of neuronal phenotype by 
members of the TGF-f3 superfamily. 
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Introduction 
Members of the neuropoietic cytokine family modulate neuronal gene 
expression (Fann and Patterson, 1994). These cytokines induce a particular set 
of neurotransmitter synthetic enzymes and neuropeptides in cultured 
sympathetic neurons, including cholecystokinin (CCK), enkephalin (ENK), 
somatostatin (SOM), substance P (SP), vasoactive intestinal polypeptide (VIP) 
and choline acetyltransferase (ChAT). In addition to these cytokines, several 
lines of evidence indicate that members of transforming growth factor 13 (TGF-
13) superfamily also regulate neuronal gene expression. For example, activin A 
induces SOM in cultured ciliary neurons and induces ChAT and several 
neuropeptides in cultured sympathetic neurons (Coulombe et al., 1993; Fann 
and Patterson, 1994). Bone morphogenetic proteins (BMP) induce the 
expression of the neural cell adhesion molecules N-CAM and L1 in 
neuroblastoma cells and stimulate PC12 cell neuronal differentiation (Paralkar 
et al., 1992; Perides et al., 1994). Although its function is unknown, 
growth/ differentiation factor 1 is expressed mainly in the nervous system 
(Lee, 1991). Dorsalin, a protein expressed preferentially in the dorsal portion 
of the developing neural tube, promotes the migration of neural crest cells and 
inhibits the formation of motor neurons (Basler et al., 1993). Glial-derived 
neurotrophic growth factor enhances the survival and differentiation of 
dopaminergic neurons (Lin et al., 1993). Thus, it is of interest to test the effects 
of TGF-13 cytokines on neuronal phenotype. 
The expression of transmitters and neuropeptides in neurons is also 
regulated by presynaptic stimulation (Patterson and Nawa, 1993). Membrane 
depolarization of neurons that mimics neuronal activity causes rapid 
alterations in protein phosphorylation (Nairn et al., 1985), and induces the 
expression of ENK, neuropeptide Y (NPY), SOM, tyrosine hydroxylase (TI-I), 
and VIP in various neurons (Goodman 1990; Morris et al., 1988; Tolon et al., 
1994; Zigmond et al., 1989). Moreover, an interaction between neuropoietic 
cytokines and membrane depolarization on transmitter and neuropeptide 
expression has been demonstrated. Depolarization blocks most of the 
noradrenergic-to-cholinergic switch induced by cholinergic neuronal 
differentiation factor /leukemia inhibitory factor (CDF /LIF) in heart cell 
conditioned medium (Walicke et al., 1977). The cholinergic activity of ciliary 
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neurotrophic factor (CNTP) is reported not to be affected by depolarization, 
however (Rao et al., 1992b). The actions of these two factors on the expression 
of neuropeptides are also differentially regulated by depolarization (Rao et al., 
1992b). These results indicate that it will also be of interest to investigate the 
influence of depolarization on gene regulation by members of the TGP-~ 
superfamily. 
One of the ways in which cytokines and growth factors can regulate 
neuronal phenotype is as target-derived factors . One of the most intensively 
studied examples of target influence is the innervation of sweat glands by 
sympathetic neurons (Landis, 1990). Upon innervating these glands, 
sympathetic neurons increase expression of ChAT, calcitonin gene-related 
peptide (CGRP), and VIP, while decreasing expression of TH. The induction 
of these traits is specific, because no other neuropeptides are detectable in 
these neurons (Landis et al., 1988). A putative factor(s) involved in this 
phenotypic transition has been partially characterized and has similar 
activities on sympathetic neurons to those of CDP /LIP and CNTP (Rao et al., 
1992a; Rohrer, 1992). However, null mutant mice that are CDP /LIP- or CNTF-
deficient display sweat gland innervation of a normal phenotype (Masu et al., 
1993; Rao et al., 1994). These results suggest that CDF/LIF and CNTF may not 
be the factor responsible for the phenotypic transition and raise the possibility 
that other cholinergic-inducing factors may be involved in this process. 
As a first step in defining the role of the TGP-~ superfamily in the 
sympathetic nervous system, we focus on effects of these factors on neuronal 
phenotype in vitro. The 24 members in the TGP-~ superfamily are distributed 
into four groups based on sequence homology: TGP, activin, dpp, and 60A 
subfamilies (Kingsley, 1994). We analyze representative members of each 
subfamily for this effect on neuronal gene expression using the reverse 
transcription-polymerase chain reaction (RT-PCR) method (Pann and 
Patterson, 1993). We find that, in addition to the activin subfamily (Pann and 
Patterson, 1994), members of the dpp and 60A subfamilies also induce a 
particular set of transmitters and neuropeptides in cultured sympathetic 
neurons. The TGP subfamily is, however, without detectable effect in the 
assay. The effect of depolarization on gene regulation by these factors is also 
analyzed. Our results demonstrate that depolarization differentially alters the 
induction patterns of neuropeptide genes by activin A, BMP-2, and BMP-6. 
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Since activin A acts as a cholinergic factor in cultured sympathetic 
neurons, inducing ChAT and CGRP expression, it was of interest to 
investigate whether this cytokine could be the sweat gland factor. We have 
used in situ hybridization, RNase protection, and analysis of neuronal gene-
inducing activities in tissue extracts to test whether members of the activin 
subfamily are present in developing sweat glands. Our results show that 
activin B is present in target tissues of both cholinergic and noradrenergic 
sympathetic neurons. The cholinergic activity in sweat gland extracts do not, 
however, resemble activins. These results suggest that the activins are not 
responsible for the phenotypic switch during sweat gland innervation. 
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Materials and Methods 
Animals and reagents 
Neonatal Sprague-Dawley rats were purchased from Simonsen 
Laboratories (Gilroy, CA). Most of the tissue culture reagents, Superscript 
reverse transcriptase II (RTase) and the 1-kb DNA marker were purchased 
from Gibco/BRL (Grand Island, NY). Nerve growth factor, glycogen, dATP, 
dCTP, dGTP, and dTTP were purchased from Boehringer Mannheim 
(Indianapolis, IN). RNase inhibitor (RNasin) and Taq DNA polymerase were 
purchased from Promega (Madison, WI). Oligo dT was obtained from 
Pharmacia (Piscataway, NJ). Oligonucleotide primers were synthesized in the 
Biopolymer Synthesis and Analysis Resource Center at Caltech. Recombinant 
human activin A was a gift from Genentech (S. San Francisco, CA). 
Recombinant proteins human BMP-2 and BMP-6 were provided by Dr. John 
M. Wozney (Genetics Institute, Cambridge, MA). Recombinant proteins 
human TGF-131 and TGF-133 were purchased from R&D Systems 
(Minneapolis, MN). All other reagents were purchased from Sigma (St. Louis, 
MO). 
Neuronal culture 
Dissociated sympathetic neurons were prepared and cultured in 
serum-free medium as described previously (Fann and Patterson, 1993; 
Hawrot and Patterson, 1979; Wolinsky et al., 1985). Neurons were seeded in 
96-well plates (Falcon; Oxnard, CA) at a density of one ganglion per well. 
Cultures were maintained for 7 days, and half of the medium was changed 
every 36 hours in an effort to ensure that cytokines maintained activity. The 
antimitotic agent, aphidicolin, was added to the cultures at a concentration of 
4 j..tg/ml to effectively eliminate non-neuronal cells. After 7 days, each well 
contained approximately 3000 neurons and about 95% of the surviving cells 
were neurons, as judged by phase microscopy (Wolinsky et al., 1985). 
Cytokines, with or without 40 mM KCl, were added from the second day of 
culture, and duplicate wells were prepared for each condition. All results 
were reproduced in at least two separate neuronal platings. 
Preparation of RNA and eDNA 
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Total tissue RNA was prepared by disruption of the tissue in 4 M 
guanidinium thiocyanate using a polytron and extraction with acidic phenol 
and chloroform (Chomczynski and Sacchi, 1987). The kit from 5-Prirne-3 
-Prime Inc. (Boulder, CO) was used to select poly-A RNA from total RNA. 
Total RNA from cultured neurons was prepared in the same manner, but 
smaller amounts of material were used (Belyavsky et al., 1989). Briefly, 160 Jll 
of lysis buffer (4 M guanidinium thiocyanate, 25 rnM sodium citrate, pH 7.0, 
100 mM 2-mercaptoethanol, 0.5% sodium lauroyl sarcosinate) was added to 
each well. The lysate was transferred to 1.7 ml eppendorf tube and vortexed 
vigorously to shear DNA. Ten ~1 of 1M sodium acetate, pH 4.0, 200 Jll of 
water-saturated phenol and 40 ~1 of chloroform were added sequentially, with 
vigorous vortexing after each addition. The samples were kept at 4 ·c for 20 
min and centrifuged at 12,000 g for 15 min. The water phase was transferred 
to a new tube containing 10 ~1 of 3 mg/ml glycogen. RNA was precipitated 
by addition of 200 ~1 isopropanol and stored at -20 ·c overnight. 
To produce eDNA from the cultured neurons, the total RNA was 
centrifuged, dried and directly dissolved in 10 ~1 of 13 mM methylmercury 
hydroxide for 10 min, and an additional2 Jll of 75 mM 2-mercaptoethanol was 
added for 5 min. Oligo-dT primed reverse transcription was done in a final 
volume of 20 ~1, containing the reverse transcription buffer, 100 U reverse 
transcriptase and 20 U RNasin, for 1 hour at 37"C. 
Polymerase chain reaction 
The sequences of the primers and conditions used in the PCR for each 
neuronal gene analyzed were described previously (Fann and Patterson, 
1993). Amplification of eDNA was performed in a thermal cycler (MJ 
Research, Watertown, MA). Each tube contained a final volume of 20 ~1, 
consisting of 1 ~1 of eDNA, 1X PCR buffer, 0.5 U Taq DNA polymerase, 0.25 
mM dNTP, and one set of primers (200 nM). After the reaction, 8 Jll of each 
PCR sample were analyzed on a 2% agarose gel, and the products were 
visualized after ethidium bromide staining and UV illumination. The 
appropriate amplification cycle schedule for each neuropeptide gene was 
determined empirically, to allow a minimal, yet detectable, signal for control 
samples (neurons grown without cytokines). Cytokines were deemed to have 
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regulatory effects on specific genes if the intensity of the PCR products were 
about three-fold different from those of negative controls, as judged by eye. 
RNase protection assay 
Plasmids containing rat inhibin a (from nucleotide 260 to nucleotide 
1398), ~A (from nucleotide 149 to nucleotide 1459), and ~B (from nucleotide 1 
to nucleotide 1562) (Feng et al., 1989; Woodruff et al., 1987) were cloned by 
PCR using embryonic day 12 placenta eDNA as template. The PCR products 
were ligated into TA Cloning kit purchased from Invitrogen (San Diego, CA) 
and sequenced to confirm their identity. GAPDH was used as internal control 
and obtained from Dr. Lisa Banner (Banner and Patterson, 1994). The assay 
was performed according to the protocol of Patterson and Fann (1992). 
Briefly, plasmids were linearized by restriction enzymes and 32P-labeled RNA 
sense probes generated by in vitro transcription were hybridized to various 
poly-A RNAs. The sizes of probes for a, ~A, ~B, and GAPDH are 466, 428, 338, 
and 206 nucleotides, respectively. These probes yielded protected fragments 
of 386 nucleotides for a, 348 nucleotides for ~A, 267 nucleotides for ~B, and 136 
nucleutides for GAPDH. Radioactivity was quantitated by scanning the 
protected fragments on a Phosphoimager 400S (Molecular Dynamic, 
Sunnyvale, CA) and computing with ImageQuant software. The intensities of 
the protected fragments corresponding to a, ~A, and ~B, were expressed as 
ratios to that of GADPH, and the values expressed in arbitrary units. 
In situ hybridization 
Antisense and sense, digoxigenin-labeled RNA probes for inhibin a 
(from nucleotide 260 to nucleotide 1398), ~A (from nucleotide 149 to 
nucleotide 1459), and ~B (from nucleotide 1 to nucleotide 1562) were 
generated using the Ambion (Austin, Texas) Megascript in vitro transcription 
kit, after digesting plasmids with restriction enzymes. In situ hybridization 
was performed according to the protocol of Birren et al. (1993). Briefly, 10 J.liil 
sections of fixed tissue were hybridized overnight with 1 J.lg/ml of either 
sense or antisense probes. The hybridization temperture for a and J3A probes 
was 6o·c, and 64 ·c for J3B probes. After RNase digestion and washing with 
0.2 X SSC, 0.3% CHAPS solution at the hybridization temperatures, sections 
were incubated overnight with an alkaline phosphatase-conjugated anti-
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digoxygenin antibody (Boehringer Mannheim). Nitro Blue Tetrazolium and 5-
bromo-4-cholro-3-indoyl phosphate were used as substrates to visualize the 
enzyme activity. 
Tissue homogenate preparation 
To prepare tissue homogenates, footpads, skin from the thoracic region, 
and submaxillary glands were dissected from P7 and P21 rats. Each tissue 
was homogenized for 20 s, three times, in 10 vol of 10 mM phosphate buffer 
(pH 7.0) with a polytron. The extracts were centrifuged at 100,000 x G for 1 
hour. The supernatants were collected and concentrated using Centricon 
filters with 10 kDa molecular weight cutoff. The protein concentration was 
determined with a Pierce (Rockford, IL) protein assay kit. 
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Results 
BMP-2 and BMP-6 induce a particular set of transmitters and neuropeptides. 
The TGF-13 superfamily includes 24 members and is divided into 4 
subfamilies, according to sequence homologies (Kingsley, 1994). We selected 
representative members from each subfamily and examined the effects on the 
expression of transmitter synthetic enzymes and neuropeptides in cultured 
sympathetic neurons by the RT-PCR method (Fann and Patterson, 1993). The 
TGF subfamily is represented by TGF-131 and TGF-133, the activin subfamily by 
activin A, the dpp subfamily by BMP-2, and the 60A subfamily by BMP-6. We 
have reported the effects of activin A on neuronal gene expression previously 
(Fann and Patterson, 1994). Activin A induces mRNAs for ChAT, CCK, 
CGRP, dynorphin (DYN), NPY, and SOM, but not ENK, SP, VIP, TH, 
tryptophan hydroxylase (TPH) and 67 kDa glutamic acid decarboxylase 
(GAD67). 
When two concentrations (40 ng/ml and 400 ng/ml) of TGF-131 or TGF-
133 were applied to neonatal rat sympathetic neurons in culture for 6 days, 
these cytokines show no effect on the intensity of PCR products for any of the 
11 genes analyzed (Fig. 1). The 13-actin band is used to monitor the amount of 
mRNA present in each sample, and duplicate samples are prepared for each 
condition. In contrast, both BMP-2 and BMP-6 elicit induction patterns of 
mRNA for neuropeptides and transmitter synthetic enzymes that are distinct 
from those of the neuropoietic cytokines and activin A. As illustrated in Fig. 2, 
BMP-2 and BMP-6 have no effect on the expression of mRNAs for ChAT, 
CGRP, GAD 67, ENK, SP, and TH. Both do induce DYN, NPY, SOM, VIP, and 
TPH in a dose-dependent manner. Although BMP-2 and BMP-6 show similar 
patterns of induction, there are two noticeable differences between the effects 
of these two factors. First, BMP-2 is more potent than BMP-6. Second, BMP-2 
induces CCK expression but BMP-6 does not. The latter difference may, 
however, be due to the lower potency of BMP-6, since CCK induction by 
BMP-2 is weak. As the members in each subfamily are highly conserved, we 
predict that the effects of TGFs, activin A, and BMPs analyzed here are 
representative of most or all family members. 
Depolarization modulates the induction patterns of activin A and BMPs. 
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Depolarization by elevation of extracellular potassium concentration 
(K+) can alter neuronal gene expression. When 40 mM K+ is added into 
cultured sympathetic neurons to mimic presynaptic stimulation, expression of 
mRNAs for CGRP and NPY is slightly increased while that for ChAT was 
decreased (Fig. 3). Depolarization also alters the induction patterns of 
neuropeptides by members of the TGF-13 superfamily (Table I). 
Depolarization inhibits expression of CGRP induced by activin A, although 
high K+ alone slightly increases CGRP. Conversely, expression of VIP is 
increased when activin A and high K+ are added together. A reverse pattern 
was observed when BMPs and high K+ were applied together. The induction 
of VW expression by BMP-2 and BMP-6 is inhibited by depolarization while 
the expression of CGRP is increased in the combination of BMP-2 and high K+. 
This dramatic difference between the effect of depolarization on CGRP and 
VIP induction by activin A versus BMP-2 and BMP-6 is surprising, as 
receptors for all these cytokines are highly conserved and all contain serine-
threonine kinase domains (Xie et al., 1994). This inhibition by depolarization 
is specific, as high K+ inhibits the induction of ChAT by activin A but has no 
effect on ChAT when added together with BMPs. Moreover, depolarization 
has no effect on other genes induced by either activin A or BMPs (CCK, DYN, 
NPY, SOM, TPH). These results are summarized in Table I. 
Activins are unlikely to be the factors involved in the switch of neuronal phenotype 
during sweat gland innervation. 
One of the most extensively studied systems of target-derived influence 
on neuronal development is the sympathetic innervation of sweat glands 
(Landis, 1990). Contact with these glands induces the innervating neurons to 
change their phenotype from noradrenergic to cholinergic. Contact with other 
targets does not induce this switch in gene expression (Schotzinger and 
Landis, 1988; 1990). In considering potential candidates for the sweat gland 
cholinergic factor, only neuropoietic cytokines and activins elicit ChAT 
expression in cultured sympathetic neurons (Fann and Patterson, 1994). To 
test whether activins are involved in vivo, we asked two questions. First, are 
the mRNAs for activins localized in footpads containing sweat glands, but not 
in skin or submaxillary glands, which are noradrenergic targets? The 
distribution of activins in these tissues was analyzed by in situ hybridization 
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and RNase protection. Second, do tissue homogenates for footpads contain 
activin-like activity when assayed on cultured sympathetic neurons? 
Homogenates were assayed by the RT-PCR method. 
The activin subfamily are dimers containing one or two of the family 
members: a, 13A- or 13B· Hetrodimers of a and either one of the 13 subunits are 
termed inhibins. Homodimers or heterodimers of 13 subunits are termed 
activins. Digoxigenin-labeled RNA probes were used to detect these three 
genes in footpads by in situ hybridization. There is no staining for the a and 
13A genes in P7 and P14 rat footpads (Figs. 4 and 5). There is, however, a 
positive signal using the 13B antisense probe. The 13B mRNA is localized in 
sweat glands but not muscle, epidermal, endothelial cells (Fig. 6). Thus, 
activin B mRNA is selectively expressed at the right time and place to be 
involved in the changes of neuronal phenotype mediated by the sweat glands. 
We next tested whether activins are present in tissues which are 
innervated by noradrenergic sympathetic axons: hairy skins and submaxillary 
glands. The mRNAs for the subunits were analyzed using the RNase 
protection method; a sample gel is shown in Fig. 7. Protected fragments were 
quantified by the Phosphoimager and expressed as ratios to the control gene, 
glyceraldehyde phosphate dehydrogenase (GAPDH) (Figs. 8). There is 
expression of the 13B gene in footpads at all stages analyzed, with a peak at P7. 
There is expression of a and 13A in footpads, also peaking at P7. Since the 
specific activities of the a and 13A probes are 3- and 2-fold higher, respectively, 
than that of the 13B probe, the relative expression of a and 13A is much lower 
than 13B· This likely explains our failure to detect a and 13A mRNAs in footpad 
by in situ hybridization. The expression of the a and 13B genes is more 
abundant in submaxillary glands than in footpads (Fig. 8). Since the amounts 
of a and 13B genes are similar in submaxillary glands, these glands may 
produce more inhibins than activins. All three genes are expressed at low 
levels in skin during development, and there is a large increase of 13B gene in 
the adult (Fig. 8). Thus, these are striking differences in the expression of the 
activins and inhibins during development and between tissues. The results do 
not, however, support the notion that activin B is selectively expressed in 
targets of cholinergic sympathetic neurons. 
To further analyze the possibility that activins participate in regulating 
the innervation of sweat glands, tissue homogenates were prepared from 
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footpads, hairy skin of the thoracic region, and submaxillary glands from P21 
rats. High speed supernatants from these homogenates were applied to 
neuronal cultures to detect neuropeptide-inducing activities by the RT-PCR 
assay. Extracts from submaxillary glands are toxic to neurons and were not 
analyzed further. Both footpad and skin homogenates at the concentration of 
400 11-g/ml induce SP, VIP, and ENK mRNAs (Fig. 9). Extracts from footpads 
but not skin induce the expression of ChAT, a result similar to that of Rao and 
Landis (1990). There is, however, no induction of CGRP and DYN, two 
neuropeptides strongly induced by activin A. Although activin A, but not 
activin B, was used as the positive control in this assay, there are no known 
functional differences between these two factors (Schwall et al., 1989). We 
obtained similar results from P7 tissue homogenates, though with lower 
neuropeptide-inducing activity (data not shown). Thus, the high speed 
supernatants of footpad extracts do not contain detectable activin activity in 




The TGF-~ superfamily presently contains 24 members. Although 
some of them are primarily located in the nervous system, the functions of 
these proteins in the nervous system are not yet clear. To detect the effects of 
this superfamily on cultured sympathetic neurons, we selected TGF-~1, TGF-
~3, BMP-2, BMP-6, and activin A as representatives of the subfamilies and 
analyzed their effects on neuronal phenotype by the RT-PCR method. Effects 
of activin A on the expression of neurotransmitters and neuropeptides have 
been reported previously (Fann and Patterson, 1994). This cytokine induces 
mRNAs for ChAT, CCK, CGRP, DYN, NPY, and SOM, but not the other genes 
analyzed. Although activins and BMPs have about 60% similarity in primary 
amino acid sequences, they display different inductive patterns of transmitters 
and neuropeptides. Both BMP-2 and BMP-6 increase the mRNA expression of 
DYN, NPY, SOM, VIP, and TPH, with BMP-2 being more potent than BMP-6. 
BMP-2 also weakly induces the expression of CCK mRNA. Although activin 
A and BMPs induce some of the same genes (CCK, DYN, NPY, and SOM), 
there are striking differences: activin A induces ChAT and CGRP while BMPs 
do not, and BMPs induce TPH and VIP while activin A does not. These 
various effects are specific in another way; TGF-~ 1 and TGF-~3 have no effects 
in the assay. 
The induction of these neuropeptides by BMPs is not abnormal, as 
Gibbins (1992) reported that VIP, NPY, and DYN co-localized in 15% of 
guinea-pig lumbar sympathetic ganglia. The induction of TPH is also not 
completely unexpected as several groups reported that sympathetic neurons 
transiently express serotonin (Garcia-Arraras and Martinez, 1990; Happola et 
al., 1986; Soinila et al., 1988). The potential involvement of BMPs in these 
inductions in vivo merits further study. The result that BMPs and activin A 
display different induction patterns of neurotransmitters and neuropeptides is 
in dramatic contrast to the picture with the neuropoietic cytokines. While 
members of the latter family have very limited sequence homology, they 
induce very similar patterns of neuropeptide induction in cultured 
sympathetic neurons (Fann and Patterson, 1994). These results suggest that, 
unlike the neuropoietic cytokines that channel signals through the same 
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receptor subunit (Kishimoto et al., 1994), the activin and BMP receptors have 
diverged to mediate different signal cascades. 
Several lines of evidence, both in vivo and in vitro, have shown that 
presynaptic activity can regulate the neuronal gene expression (Castren et al., 
1992; Goodman, 1990). Recent progress suggests that calcium influx through 
voltage-sensitive calcium channels (VSCC) is involved (Franklin and Johnson, 
1992; Ghosh et al., 1994). Depolarization inhibits the sympathetic neuron 
phenotypic switch induced by CDF /LIF (Walicke et al., 1977). This inhibition 
is Ca+2-dependent and may utilize VSCC (Walicke and Patterson, 1981). To 
test whether depolarization modulates the effects of BMP-2, BMP-6 and 
activin A, we applied these cytokines to sympathetic neuronal cultures in the 
presence of high K+. Our results demonstrate that depolarization 
differentially regulates the effects of BMPs and activin A (Table I). High K+ 
strongly decreases the induction of CGRP and ChAT by activin A, but has a 
synergistic effect with activin A on the expression of VIP. Very different 
effects of depolarization are observed with BMP-2 and BMP-6. Depolarization 
decreases the induction of VIP expression by BMP-2 and BMP-6, but has 
synergistic effects with BMP-2 on the expression of CGRP. The fact that 
depolarization does not change the expression of other genes illustrates the 
specificity of these effects. These results demonstrate the complexity of 
neuronal gene regulation: the same gene is differentially regulated by 
homologous proteins and presynaptic stimulation. 
Coulombe et al. (1993) have shown that activin A is the likely factor in 
the eye to induce the expression of SOM in choroid neurons. Since activin A 
also induces the expression of ChAT and CGRP in sympathetic neurons, we 
asked whether this cytokine could be involved in the phenotypic switch 
mediated by the sweat gland. We performed in situ hybridization and 
demonstrated that the message for activin B is present in sweat glands but not 
in other cells of the footpad. The other two genes in activin subfamily could 
not be detected by the in situ technique. To determine whether activin B 
mRNA is also expressed in tissues innervated by noradrenergic sympathetic 
axons, the RNase protection assay was utilized. The ~B mRNA is present in 
footpads at all time points analyzed, with a peak at P7. The other two genes, a 
and ~A, are expressed at lower levels in footpads. This result is consistent to 
our in situ hybridization result. The mRNA for the ~B gene is, however, also 
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found in skin and submaxillary glands. The expression of the l3B gene in 
submaxillary glands is higher than in footpads at all corresponding time 
points. Since submaxillary glands also express higher amounts of the a gene, 
it is likely that submaxillary glands form more inhibin B protein than activin B 
protein. Skin also contains similar level of expression of the l3B gene to that of 
footpads at early stages of development. There is, however, a dramatic 
increase of l3B mRNA in adult skin. Whether this increase correlates with any 
developmental change in skin requires further analysis. Together, these 
results indicate that the expression of the l3B gene is not only in footpads but 
also in targets of noradrenergic sympathetic neurons. 
Further evidence that activins are not the factors involved in the 
phenotypic switch of the sweat gland innervation comes from analysis of 
footpad homogenates. When these homogenates are added to cultured 
sympathetic neurons, an induction of mRNAs for SP, ENK, VIP, and ChAT is 
detected. This induction pattern is similar to that of the neuropoietic 
cytokines, but is different from that of activins. There is no increase of the 
expression of CGRP and DYN, which are two neuropeptides strongly induced 
by activin A. Since the detection sensitivity of RT-PCR assay for activin A is 
about 5 ng/ml (Fann and Patterson, 1994), it means that less than 5 ng/ml of 
activins are present in 400 j..tg/ml of footpad extract. The fact that less than 
1/80000 of total proteins in footpads may be an activin makes these cytokines 
less likely candidates for the sweat gland factor. Since the induction pattern of 
footpad extract is similar to that of the neuropoietic cytokines, these are more 
likely candidates for the sweat gland factor. 
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Figure 1. TGF-{31 and TGF-{33 have no effect on neuronal gene expression. 
Two concentrations (40 ng/ml and 400 ng/ml) of TGF-~1 or TGF-~3 
were added into cultured sympathetic neurons for six days. The expression of 
mRNAs for 11 transmitter synthetic enzymes and neuropeptides was 
analyzed by RT-PCR. Duplicate samples were prepared for each condition. 
The ~-actin PCR product was used to monitor the amount of mRNA present in 




















Figure 2. BMP-2 and BMP-6 selectively induce the expression of mRNAs for 
several neuropeptides and TPH. 
Neonatal rat sympathetic neurons were cultured with different 
concentrations (ng/ml) of BMP-2 and BMP-6 for six days. Duplicate samples 
were prepared for each condition. Total RNA was extracted from cells after 
the end of the incubation and the expression of mRNA for 12 transmitter 
synthetic enzymes and neuropeptides was analyzed by PCR. The intensity of 
13-actin PCR product was used to monitor the amount of mRNA present in 
each sample. BMP-2 and BMP-6 strongly increase the expression of DYN. 
Both cytokines also enhance the expression of NPY, SOM, TPH and VIP. CCK 
is weakly induced by higher concentrations of BMP-2. ChAT, CGRP, ENK, 
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Figure 3. The effect of depolarization on neuropeptide induction by activin A, 
BMP-2, and BMP-6. 
Neonatal rat sympathetic neurons were cultured in the presence of 
cytokines, with or without 40 mM KCl (K+) for six days. The concentrations of 
cytokines were 50 ng/ml for activin A, and 100 ng/ml for BMP-2 and BMP-6. 
Duplicate samples were prepared for each condition. Depolarization of cells 
alone (C, +) slightly increases the expression of CGRP and NPY, while 
decreasing the expression of ChAT. The induction of ChAT and CGRP by 
activin A is inhibited by depolarization. Expression of VIP, however, is 
enhanced when activin A and K+ are added together. The induction of VIP by 
BMP-2 and BMP-6, in contrast, is inhibited by depolarization. Expression of 
CGRP is enhanced when BMP-2 and K+ are added together. Although 
depolarization enhances CCK expression induced by activin A in this panel, 
this effect was not observed in other experiments. We cannot consistently 
demonstrate that depolarization inhibits SOM expression induced by BMP-6 
either. Depolarization has no effect on other genes analyzed. 
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Table I. Summary of depolarization effect on neuropeptide induction by 
activin A, BMP-2 and BMP-6. 
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activin A BMP-2 BMP-6 
K+ - + - + - + 
CGRP 4 - - + - -
VIP - ; + - ; -
ChAT 4 - - - - -
CCK 4 ; + + - -
DYN 4 4 + + ; 4 
NPY 4 4 ; ; + + 
SOM 4 4 ; ; ; ; 
TPH - - + + + + 
; : induced; - : uninduced 
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Figure 4. The message for the inhibin g, subunit is not detectable in sweat 
glands by in situ hybridization. 
Ten j..Lm sections of P14 footpads were hybridized with sense or 
antisense inhibin a probes labeled with digoxigenin. After washing and 
RNase digestion, sections were reacted with an alkaline phosphatase-
conjugated anti-digoxigenin antibody and were developed with enzyme 
substrates. There is no difference on the staining between sections labeled 
with sense or antisense probes. Scale bar is 40 j..Lffi. 
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Figure 5. The message for the activin 13A subunit is not detectable in sweat 
glands by in situ hybridization. 
Sections of P14 footpads were processed in the same way as in Fig. 4. 
There is no difference on the staining between sections labeled with sense or 




Figure 6. The message for the activin l3B subunit is present in sweat glands by 
in situ hybridization. 
Sections of footpads were processed in the same way as in Fig. 4. 
Specific hybridization to sweat glands is seen with the antisense probe. Scale 
bar is 20 11m. 
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P14 B8 antisense 
' • .. 
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Figure 7. RNase protection analysis of mRNAs for q,, (3A, and f3B activins. 
Footpads (FP), submaxillary glands (S. G.), and skin were dissected 
from rats at various developmental stages. RNA was extracted and 
expression of the a, ~A, and ~B genes were assayed by the RNase protection 
method, as described in the Methods section. Arrows on the right side of the 
panel delineate the sizes of undigested probes. The size of the undigested 
GAPDH probe is not shown. Arrows on the left side of the panel delineate the 
predicted sizes of the protected probes. tRNA (tRNA) was used as a negative 













Materials and Methods 
Most of the experimental procedures used are described in Chapter 4 
with the following exception. 
Cell culture 
Heart cell CM was prepared in serum-free rnedi urn developed by 
Fukada (1980) . Neonatal rat sympathetic neurons were prepared and cultured 
in serum-free medium as described previously (see Chapter 4). PBS-dialyzed 
column fractions were mixed with the same volume of neuronal medium and 
sterilized through 0.21J.rn filters before being added into neuronal culture. 
Biochemical separation of active components 
The fractionation of proteins was accomplished by Jane Talvenheimo 
and Lin Cai at Amgen, Inc. (Thousand Oaks, CA). Most of the separation 
steps were done at 4°C. The proteins in heart cell CM were precipitated by 
80% (W /V) saturation of ammonium sulfate, and the pellet was dialyzed 
against 10 volumes of the buffer containing 5 rnM Tris-HCl (pH 7.1) (Fukada, 
1985). The dissolved precipitate was loaded on a 2 ern x 25 ern, 50 ml bed 
volume Q-Sepharose column (Pharrnacia) preequilibrated with the same 
buffer. The column was washed with 5 mM Tris-HCl at the same volume of 
applied sample, which were collected as the flow-through fraction. Then the 
column was eluted with a linear gradient of 0 to 1M NaCl in 5 mM Tris-HCl 
buffer at a flow rate of 5 ml/rnin. Every 30 rnl were collected into one fraction. 
A total of 24 fractions were collected. 
Sephadex G-100 and G-75 (superfine grade) columns were used for gel 
filtration analysis. Samples were applied to a 2 ern x 100 ern, 300 ml bed 
volume Sephadex columns equilibrated in PBS, pH 7.3. The columns were 
eluted with the same buffer at the flow rate of 1 ml/min. Each fraction 
contained 6 rnl and 50 fractions were collected. The columns were calibrated 
with aldolase (158 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa) 
and chymotrypsinogen (25 kDa). 
Lentil lectin and Concanavalin A columns were purchased from 
Pharmacia. The Q-Sepharose flow-through fractions in PBS (pH 7.3) were 
concentrated to 100 rnl and supplemented with 1 mM MgCl2 and MnCl2 prior 
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to application to the lentil lectin column. Samples were mixed with 75 rnl of 
lentil lectin agarose, the material transferred to a column (2.6 ern x 25 ern) for 
washing with 150 rnl of a buffer containing 40 rnM Tris-HCl, 100 rnM NaCl, 1 
rnM MgCl2, and 1 rnM MnCl2, pH 7.2, and eluted in one fraction with 200 ml 
0.3 M a.-rnethylrnannoside in the same buffer. The lentil lectin column flow-
through fraction, which contains about 98% of the starting protein, was 
concentrated to 100 rnl prior to application to a 50 rnl Concanavalin A (ConA) 
agarose column (2.6 ern x 25 ern). The column was washed with 100 ml of a 
buffer containing 40 rnM Tris-HCl, 100 rnM NaCl, 1 rnM MgCl2, and 1 mM 
MnCl2, pH 7.2. The protein bound to the ConA column was eluted into a 
fraction with 100 rnl of the same buffer containing 0.3 M a.-rnethylrnannoside. 
The lentil lectin eluate, the ConA eluate and the ConA flow-through fraction 
were extensively dialyzed against 20-fold volume of PBS, and then 
concentrated to 10 rnl before being added to the neuronal culture. 
Fractions eluted from lectin columns were further concentrated to 400 
~-tl, dialyzed against water, and acidified to a final concentration of 80% buffer 
A (0.1 % TFA) plus 20% buffer B (0.1 % TFA, 90% CH3CN) prior to application 
to a C4 reverse phase HPLC column (4.6 x 250 rnrn; Waters). The material 
was eluted with a linear gradient of 20% to 80% buffer B at a flow rate of 1 
rnl/rnin. One rnl was collected into each fraction so that the fraction number 
corresponded to the elution time. Absorbance was monitored at 214 nm. 
Fractions were dried and then re-dissolved in 2 rnl PBS before being added to 
the neuronal culture. 
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Results 
Several neuropeptide-inducing activities exist in Q-Sepharose fractions. 
Nawa and Patterson (1990) reported that heart cell CM contains at least 
three different proteins with neuropeptide-inducing activities and these 
proteins can be separated by anion exchange columns. We therefore adopted 
a Q-Sepharose anion exchange column as a first purification step. Five liters 
of serum-free heart cell CM were concentrated by ammonia sulfate 
precipitation, dialyzed against 5 mM Tris-HCl buffer at neural pH, applied to 
a Q-Sepharose column in the same buffer, and eluted with a zero to 1M NaCl 
gradient. Fig. 1 shows the protein elution profile of Q-Sepharose 
chromatography. Most of the protein was eluted as a single peak. These 
fractions (containing negatively charged proteins) as well as flow-through 
fractions (containing positively charged proteins) were analyzed for their 
transmitter- and neuropeptide-inducing activities on cultured sympathetic 
neurons by the RT-PCR method. Fractions 4 and 6-10 have ChAT-, SOM-, SP-, 
and YIP-inducing activity (Fig. 2). There is, however, almost no detectable 
VIP signal in either the original heart cell CM or the column flow-through 
(Fig. 2). This result was unexpected, since the CM and the column flow-
through should contain CDF /LIF, which induces VIP. Because signals for 
other neuropeptides are also weak in the original CM and flow-through 
fractions, it is possible that the active factors were either too dilute to be 
detected, or perhaps subject to inhibition by other components before 
purification. To address these concerns, the Q-Sepharose flow-through 
fractions were concentrated and assayed again (Fig. 3). An aliquot was also 
applied to a Sephadex G-100 column to assess the molecular weight (MW) of 
the YIP-inducing activity. When concentrated, the Q-Sepharose flow-through 
fractions display activity similar to that of CDF /LIF. Weak VIP and a 
significant SP signal are found in the 50-70 kDa fractions from the gel filtration 
column. Thus, our results from this anion exchange column are similar to 
those of Nawa and Patterson (1990) who used a different anion exchange 
column, and the MW of these activities is similar to that previously reported. 
Isolation of SOM-inducing activity from the acidic protein fractions. 
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Since there was a SOM-inducing activity from the Q-Sepharose 
fractions (Fig. 2), we first worked on isolation of this activity from the acidic 
proteins. Nawa and Patterson (1990) found a SOM-inducing activity in heart 
cell CM that is distinct from CDF /LIF with an apparent MW of 45 kDa by gel 
filtration. We find a similar activity in the Q-Sepharose fractions. Fractions 4 
and 8 were each applied to a Sephadex G-100 column, and bioassay results are 
shown in Fig. 4. Although Q-Sepharose fraction 4 continues to give a strong 
SOM signal in this assay, Q-Sepharose fraction 8 no longer exhibits activity. 
There is, however, no activity in any of Sephadex G-100 fractions derived from 
either Q-Sepharose fraction. There are at least three explanations for the 
negative results: (1) the SOM-inducing activity is labile, (2) the gel filtration 
fractions were too dilute, or (3) multiple components required for activity 
were separated by the gel filtration step. To test the possibility that samples 
were too dilute, we concentrated aliquots of the gel filtration fractions and 
assayed these fractions again (Fig. 5). The Sephadex G-100 fractions derived 
from Q-Sepharose fraction 4 still showed no activity, even though fraction 4 
itself continued to induce SOM. This indicated that SOM-indudng activity in 
Q-Sepharose fraction 4 might contain multiple components that were 
separated by the gel filtration step. In contrast, a SOM signal is detected in the 
concentrated fraction with 73-100 kDa MW range derived from Q-Sepharose 8 
and in concentrated Q-Sepharose fraction 8. Taken together, these results 
suggest that the SOM-inducing activity detected in the assay shown in Fig. 2 is 
labile or consists of multiple components. In other Q-Sepharose preparations 
using CM that had been stored in freezers for long periods, SOM-indudng 
activity was difficult to detect. Thus, the purification of SOM-indudng 
activity was not pursued further. 
Isolation of VIP-inducing activity from the basic protein fractions. 
In order to separate CDF /LIF from non-CDF /LIF VIP-inducing 
activities in the Q-Sepharose flow-through fraction, we used lentil lectin 
chromatography to eliminate most of CDF /LIF, a scheme used by other 
investigators to purify CDF /LIF to homogeneity (Hilton et al., 1988). The Q-
Sepharose flow-through fractions were mixed with 75 ml of lentil lectin 
agarose, the material transferred to a column for washing, and eluted with a-
methylmannoside. We expected CDF /LIF to be present in the glycoprotein 
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fraction eluted from this column. The lentil lectin column flow-through 
fraction, which contains about 98% of the starting protein, was applied to a 50 
ml Concanavalin A (ConA) agarose column to remove any residual CDF/LIF 
(ConA and lentil lectin have similar carbohydrate binding specificity, ConA 
having a higher affinity). This scheme produced four samples for assay: (1) Q-
Sepharose flow-through (100% of starting protein), (2) Lentil lectin eluate (2% 
of starting protein), (3) ConA flow-through (96% of starting protein), and (4) 
ConA eluate (2% of starting protein). The assay results for these samples are 
shown in Fig. 6. SP and ChAT are strongly induced by the lentil lectin eluate, 
consistent with the presence of CDF /LIF in this fraction. The ConA eluate 
also induces SP and ChAT, but less strongly than the lentil lectin eluate. VIP 
is induced more strongly in the ConA eluate than in the lentil lectin eluate, 
suggesting that the ConA eluate may contain, in addition to CDF /LIF, a novel 
VIP-inducing activity. We were unable to obtain conclusive results for the 
ConA flow-though fraction in this assay because it was toxic to the neurons. 
To further separate CDF /LIF from other VIP-inducing activities, we 
subjected the ConA eluate to reverse phase HPLC. To test where CDF /LIF is 
eluted from HPLC, the lentil lectin eluate was applied to a Superdex 75 
column. The fractions in the MW range of 20 to 90 kDa were pooled and run 
on a C4 HPLC column in 80% buffer A (0.1% TFA) plus 20% buffer B (0.1% 
TFA, 90% CH3CN), and eluted with a linear gradient of 20% to 80% buffer B 
(Fig. 7). The fractions containing CDF /LIP were identified by three assays: (1) 
Immunoblots using an anti-CDF /LIP antiserum (Yamamori et al., 1989) 
reveals a broad band, possibly a doublet, at 40 kDa in fraction 37 (Fig. 8), 
which elutes at 68% buffer B; (2) N-terminal sequencing of fraction 37 
confirms it as CDF /LIP; (3) The bioassay detected CDF /LIP-like activity in 
fractions 36 and 38 (Fig. 9, H36 and H38). We conclude that the lentil lectin 
eluate from the Q-Sepharose flow-though contains CDF /LIP and that this may 
be the only activity detectable after reverse phase HPLC. 
We next subjected the ConA eluate to HPLC using similar conditions 
(Fig. 10). Immunoblot analysis does not detect a CDF /LIF band in the ConA 
eluate and the ConA flow-through fraction (Fig. 8, ConA E and ConA Fr), nor 
in its HPLC fractions (data not shown). The bioassay results (Fig. 11) revealed 
that the early-eluting HPLC fractions (4, 5, and 21-26) contain moderate 
ChAT-inducting activity distributed over several protein peaks. Moderate 
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VIP and ENK signals are obtained with fractions 25-27, overlapping the 
ChAT-inducing activity. The lack of SF-inducing activity in these fractions is 
notable. Fractions 31 and 32 show CDF /LIF-like activities, inducing SP 
expression. Fractions 39-43 exhibit moderate VIP and CCK induction without 
SP induction. Since we had not observed a combination of VIP- and CCK-
inducing activities previously, fractions 39-43 were combined together as Pool 
3 and assayed again. In the repeat assay this sample had no activity, 
suggesting that this sample was not stable. We also combined fractions 25-27 
as Pool1 and fractions 31-32 as Pool2 and examined them by SD5-PAGE and 
silver-staining (Fig. 12). Pool 1 contains major bands at 78, 41, and 37 kDa, as 
well as other minor bands. While the 37 and 41 kDa bands are in the size 
range of CDF /LIF, the lack of SP induction by this pool indicates that if these 
bands are the active agents, these are novel proteins. Pool2 (containing the 
CDF /LIF-like activity) displays one major band at 78 kDa and several minor 
bands. There is no band detectable at the MW range expected for CDF/LIF. 
No protein bands are detectable in Pool3. 
VIP-inducing activity was lost during the larger scale of purification. 
To produce a larger quantity of material for purification, we utilized 20 
L heart cell CM and a sample provided by Dr. K. Fukada. The latter material 
represents 200 L of heart cell CM that had been passed through a DEAE 
column to remove the acidic protein fraction, then through a CDF/LIF affinity 
column using CDF/LIF antisera to remove CDF/LIF (Fukada et al., 1991). 
This sample should provide a good source for non-CDF/LIF activities. 
Twenty liters of CM were treated as described in the flow chart shown 
in Fig. 13. Samples were concentrated, buffer-exchanged, and passed over a 
Q-Sepharose column at neural pH to separate acidic and basic proteins. The 
Q-Sepharose flow-through fractions containing basic proteins were applied to 
a lentil lectin column, and the lentil lectin column flow-through was applied 
to a ConA column. This procedure yielded three samples: the lentil lectin 
eluate (proteins specifically absorbed by lentil lectin), the ConA eluate 
(proteins that passed through the lentil lectin column but bound to the ConA 
column), and the ConA flow-through (protein that did not bind to either lectin 
column). The ConA flow-through fraction contains about 95% of the protein 
from the original Q-Sepharose flow-through. The sample from K. Fukada was 
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first dialyzed extensively against PBS, then applied to lentil lectin and ConA 
columns. Bioassay results for fractions from these preparations are shown in 
Fig. 14. Most of the neuropeptide-inducing activity appears in the lentil lectin 
eluate and the ConA eluate, the two samples enriched in glycoproteins. 
Surprisingly, only a weak VIP-inducing activity is observed in fractions 
derived from K. Fukada's sample. Moderate VIP-inducing activity is present 
in lentil lectin eluate and ConA eluate derived from Q-Sepharose flow-
through. The CCK-inducing activity eluted from lentil lectin column appears 
to have been lost upon ConA chromatography. A major difference between 
the results from this large scale lentillectin-ConA preparation and those from 
the first analyticallentillectin-ConA procedure is the absence of a 
neuropeptide-inducing activity that lacks SP induction. That is, unlike the 
first lentillectin-ConA experiment, the second preparation does not have a 
clear, non-CDF /LIF activity. 
Because the lentil lectin eluate and ConA eluate derived from these two 
sources of starting material display similar activity profiles, we combined 
samples from these two sources. The pooled lentil lectin eluate and pooled 
ConA eluate were each subjected to reverse phase HPLC purification under 
identical conditions. The bioassay results for two sets of HPLC fractions are 
shown in Figs. 15 and 16. HPLC fractions derived from the pooled lentil lectin 
eluate show a broad peak of CDF /LIP-like activity centered on fractions 30-35 
(Fig. 15). Surprisingly, HPLC fractions derived from the ConA eluate also 
show a broad peak of CDF /LIP-like activity centered on fractions 30-35 (Fig. 
16). To determine whether the ConA eluate contains any non-CDF/LIF 
activity, we re-tested the activity of both ConA eluate and HPLC fractions 30-
35 in the presence of a CDF /LIF neutralizing antiserum. This antiserum 
blocks the activity in the ConA eluate and in the HPLC fractions derived from 
it (Fig. 17). After treatment with the antiserum, the ConA eluate shows only 
very weak induction of VIP and ChAT, slightly above the background level 
induced in the negative control. The early-HPLC fractions from the lentil 
lectin eluate, fractions 22-24, had weak VIP, SP, and ENK-inducing activity 
(Figs. 15). Thus, unlike the first analyticallentillectin-ConA preparation, the 
large scale, second preparation contains primary CDF /LIF as the 
neuropeptide-inducing protein. There is, however, some residual VIP-
inducing activity in the ConA flow-through fraction. 
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Discussion 
Our primary goal was to identify non-CDF /LIF, neuropeptide-
inducing factors. Nawa and Patterson (1990) reported that heart cell CM 
contains two non-CDF /LIF factors that induce expression of VIP or SOM in 
cultured sympathetic neurons. The SOM-inducing activity adsorbed to an 
anion exchange column when applied in low salt at neutral pH, and has an 
apparent MW of 45 kDa. The VIP-inducing activity, by contrast, is a basic 
protein with an apparent MW of 80 kDa. 
We were able to confirm that the SOM-inducing activity is an acidic 
protein(s) that adsorbed to a Q-Sepharose column. We lost this activity when 
we attempted further purification through gel filtration, however. Moreover, 
later preparations of heart cell CM which were stored in freezers longer than 6 
months contain very low level of SOM-inducing activity in such Q-Sepharose 
fractions. Thus, it is reasonable to assume that this activity is labile. 
We also attempted to identify the VIP-inducing activity that co-exists 
with CDF /LIF in the Q-Sepharose flow-through fraction. CDF /LIF was 
effectively eliminated by the lentil lectin affinity column in our initial, 
analytical experiment. Three distinct activities were demonstrated after the 
ConA column and reverse phase HPLC. One of the activities (Pool2, HPLC 
fractions 31 and 32, Fig. 11) may be residual CDF /LIF, as judged from its 
pattern of neuropeptide induction. Another activity (Pool1, HPLC fractions 
25-27, Fig. 11) is more hydrophilic than CDF/LIF and induces ChAT, ENK, 
VIP, but not SP expression. The other activity (Pool3, HPLC fractions 39-43, 
Fig. 11) increases expression of CCK and VIP without inducing SP, and has 
more hydrophobic properties. A large scale preparation that combined 20 1 of 
heart cell CM and a sample equivalent to 200 1 of heart cell CM provided by 
Dr. Fukada was purified using the same scheme and failed to reproduce 
similar results. Instead, most of the VIP-inducing activity was attributed to 
CDF /LIF. We did observe VIP-inducing activity in early HPLC fractions 
derived from lentil lectin eluate. Those fractions contain< 5% of the total CM 
protein. Since the second preparation of heart cell CM had been stored in 
freezers for more than two years or processed through several columns (Dr. 
Fukada's sample), a likely reason for the lack of reproducibility of the initial 
data is a loss of this novel VIP-inducing activity. The use of fresh heart cell 
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CM with minimal storage time in freezers seems important for isolation of 
both the SOM- and VIP-inducing factors. 
The purification of VIP-inducing activity is also hampered by the 
contamination of CDF /LIF in the Q-Sepharose flow-through fraction. Since 
CDF /LIF also induces VIP expression, elimination of CDF /LIF in the early 
steps of purification is necessary to detect the novel VIP-inducing activity. 
This may be feasible through repeated lentil lectin chromatography or 
through a CDF/LIF affinity column. Although we failed to eliminate 
CDF /LIF using these steps in our second preparation, it may be that the 
column was overloaded. An alternative approach would be to obtain heart 
cell CM from CDF/LIF-deficient mice (Escary et al., 1993; Stewart et al., 1992). 
The RT-PCR assay employed for this purification purpose could also be 
modified as well. The length of time required for the bioassay is nine days. 
Most of this time is for incubating the neurons (six days). It may be worth 
investigating various cell lines to reach a faster bioassay response. In addition, 
this assay is qualitative and does not allow calculation of specific activities for 
each fraction. Whether the assay should be upgraded to a quantitative PCR is 
worth considering. 
An alternative approach to identify these neuropeptide-inducing 
factors is by expression cloning. We attempted to find novel factors from a 
neonatal brain expression library using cultured sympathetic neurons and the 
RT-PCR assay without success. The major technical obstacle was a 
background problem. We had many false-positive clones, because variations 
of culture condition for Cos cells (or any other protein-generating cells in vitro) 
can have effects on the cultured neurons. Maintaining very uniform neuronal 
cultures is also very difficult. Neuronal cell lines could be useful in this 
respect. Another question in the expression cloning approach is the size of 
each pool used in the first screen. This is related to the sensitivity of the assay 
and the yield of the expression plasmid. The sensitivity of the assay seems 
dependent on the proteins of interest. We can consistently detect CNTF and 
CDF/LIF at concentration of >1 ng/ml (Fann and Patterson, 1993). For 
activins and BMP, 5 ng/ml are required. This assay is not nearly as sensitivie 
as those used for expression cloning of interleukins. Thus, the size of each 
pool cannot be too large. Our preliminary results indicate that 300 colonies 
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per pool may be the upper limit, which means that many pools are needed to 
screen the library. 
In summary, we have provided further evidence for the existence of 
novel neuropeptide-inducing factors. Although we were unable to purifiy 
these proteins to homogeneity, the lessons learned from it may benefit other 
researchers for pursuit of these factors. 
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Figure 1. Anion exchange chromatography of heart cell conditioned medium. 
1.8liters of concentrated heart cell CM were applied to a column of Q-
Sepharose equilibrated at 4DC in a buffer containing 5 mM Tris-HCl at pH 7.1. 
The column was eluted with 1.7liters of equilibrated buffer that were 
collected as two fractions (FT1 and FT2), followed by a 720 mllinear gradient 
of zero to 1M sodium chloride that were collected in 24 fractions. Sodium 
chloride concentration was measured by a conductivity monitor and the 
protein concentration of each fraction was determined using the Bio-Rad 
protein assay kit. 
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Figure 2. The profile of neuropeptide-inducing activities in 0-Sepharose 
fractions. 
An aliquot (1 ml) of each Q-Sepharose fractions (shown in Fig. 1) was 
dialyzed against PBS (pH 7.3), mixed with the same volume of serum-free 
neuronal cultured medium and filtered. Sympathetic neurons were growing 
in this 50% column fraction medium for six days. One ml of heart cell CM 
(HC CM), (NI-14hS04 precipitate after dialysis (P), and heart cell serum-free 
medium (HC M, which nerve contacts heart cells) were also mixed with 1 ml 
neuronal cultured medium and added to the neurons. Another control (C) 
was neurons cultured in neuronal medium only. The expression of mRNAs 
for transmitter synthetic enzymes and neuropeptides was analyzed by the RT-
PCR assay. Duplicate samples were prepared for each condition, and the 13-
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Figure 3. Q-Sepharose flow-through fractions contain VIP-inducing activity. 
Q-Sepharose fractions Ffl and FT2 were concentrated five-fold before 
being added to neuronal culture. An aliquot of FT2 was also applied to a 
Sephadex G-100 column to measure the apparent MW of VIP-inducing 
activity. The MW ranges were estimated based on calibration of the column 
















Figure 4. The neuropeptide-inducing profile of Sephadex G-100 fractions 
derived from Q-Sepharose fractions 4 and 8. 
148 mg of protein from Q-Sepharose fraction 4 (F4) and 8 (F8) were 
applied to a column of Sephadex G-100 column to further purify SOM-
inducing activity. The MW ranges (kDa) were estimated based on calibration 








Figure 5. The profile of neuropeptide-inducing activity in concentrated 
Sephadex G-100 fractions. 
Fractions from a Sephadex G-100 column were concentrated five-fold 
before being subjected to the neuronal assay. Q-Sepharose fractions 4 and 8 
(F4 and F8) were concentrated two-fold. The fractions derived from FB with 
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Figure 6. Bioassay of fractions from sequential lentil lectin and ConA 
columns. 
The Q-Sepharose flow-through (Q. FT) fraction was applied to a lentil 
lectin column. The absorbed protein was eluted in a single fraction (LL E) 
with 0.3 M a.-methylmannoside. The lentil lectin column flow-through 
fraction was applied to a ConA agarose column. The absorbed protein was 
eluted in a single fraction (ConA E) with 0.3 M a.-methylmannoside. The 
ConA column flow-through was also collected in a single fraction (ConA FT). 
These samples were extensively dialyzed against PBS before being assayed on 
the neuronas. Neurons were not healthy in ConA FT. 
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Figure 7. Reverse phase HPLC fractionation of the lentil lectin eluate. 
Eluted material from the lentil lectin column was concentrated, 
dialyzed against PBS and loaded on a Superdex 75 column. The fractions in 
the MW range of 20 to 90 kDa were pooled, concentrated, dialyzed against 
water, and acidified to a final concentration of 0.1% tetrafluoroacetic acid 
(TFA). Reverse phase HPLC was performed on a C4 column in 80% buffer A 
(0.1% TFA) plus 20% buffer B (0.1% TFA, 90% CH3CN) and eluted with a 
linear gradient of 20% to 80% buffer Bat 1 ml/min. One ml was collected into 
each fraction so that the fraction number corresponds to the elution time. 
Absorbance was monitored at 214 nm. The solid line is protein concentration 
profile. The dotted line is generated by the detector artificially to separate 
overlapping peaks, which does not relate to the fractions collected. The 
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Figure 8. Immunoblot of lentil lectin, its HPLC, and ConA fractions using an 
anti-CDF /LIP antiserum. 
Proteins in the ConA eluate (ConA E), the ConA flow-though (ConA 
FT), the lentil lectin eluate (LL E) and the HPLC fractions derived from lentil 
lectin eluate were separated by 10-20% gradient SD5-PAGE. After blotting, 
the nitrocellulose strips were incubated with 1: 100 anti-CDF /LIP N-terminal 
peptide antiserum and developed with alkaline phosphatase substrates. Only 
the bands at 43 and 37 kDa can be reversed by incubating the antiserum with 
recombinant CDF /LIP (data not shown). Other bands are therefore cross-
reactive proteins. Incubation of the strips with preimmune serum did not 
reveal any bands (data not shown). 
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Figure 9. Bioactivity analysis of Superdex 75 fractions and reverse phase 
HPLC fractions derived from lentil lectin eluate. 
The lentil lectin eluate was subjected to the Superdex 75 column 
chromatography. Fractions 21-23 derived from this column were further 
separated by reverse phase HPLC (see Fig. 7). Superdex fractions (S) (MW 
about 20-90 kDa) and HPLC fractions (H) were also subjected to the neuronal 
assay. Only 1/100 of HPLC fraction 37 (H37) was applied to the neuronal 
assay, because most of this fraction was used for peptide sequencing. 
Superdex fractions 19, 20 and 24 display a typical CDF /LIF neuropeptide 
inductive pattern. HPLC fractions 36, 37, and 38 contained CDF /LIF-like 
activity. 




Figure 10. Reverse phase HPLC chromatography of the ConA eluate. 
The ConA eluate was concentrated, dialyzed against water, and 
acidified to a final concentration of 0.1% TFA. Reverse phase HPLC was 
performed on a C4 column in 70% buffer A (0.1% TFA), and 30% buffer B 
(0.1% TFA, 90% CH3CN) and eluted with a linear gradient of 30% to 80% 
buffer Bat 1 ml/min. One ml was collected into each fraction so that fraction 
number is corresponding to the elution time. Absorbance was monitored at 
214 nm. The solid line is protein concentration profile. The dotted line is 
generated by the detector artificially to separate overlapping peaks, which 
does not relate to the fractions collected. The elution time of each peak is 
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Figure 11. Bioactivity analysis of ConA eluate and its reverse phase HPLC 
fractions. 
The ConA eluate was subjected to reverse phase HPLC (see Fig. 10). 
Fractions were evaporated to dryness, resuspended in PBS, and assayed on 
cultured sympathetic neurons. Fractions 25-27 contained ChAT-, ENK- and 
VIP-inducing activity, but not SP-inducing activity. CDF /LIP-like activity 
was present in fractions 31 and 32. A broad CCK- and VIP-inducing activity is 
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Figure 12. SDS-PAGE analysis of HPLC fractions derived from the ConA 
eluate. 
HPLC fractions from the ConA eluate were combined into three pools 
according to their neuropeptide-inducing activity. An aliquot of each pool 
was analyzed by 10% SDS-PAGE and silver staining. The sizes (kDa) of the 
MW standards are shown on the left side of the panel. Pool 1 (I) contains 
several major and minor bands. Pool 2 (II) contains one major and several 
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Figure 13. Flow chart of purification steps. 
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Conditioned medium 
Precipitate with 80% (~)2504 
Redissolve and dialyze with 5 mM Tris-HCl, pH 7.1 
l 
Q-Sepharose in 5 mM Tris-HCI, pH 7.1 
l 
Elute with 5 mM Tris-HCI, pH 7.1---+-1 M NaCI, 5 mM Tris-HO, pH 7.1 
Q-Sepharose flow-through 
(CDF /LIF, VIP-factor) 
l 
Lentil lectin agarose 
l 
Elute with 0.3 M a-methylmannoside 




Lentil lectin fraction 
(CDF/LIF) 
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Reverse phase HPLC 
Elute with 0.3 M a-methylmannoside 
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Figure 14. Bioassay of fractions from sequential lentil lectin and ConA 
columns derived from 20 liters of heart cell CM and from Dr. Fukada's 
sample. 
The purification procedure was as described for Fig. 6. The 
concentration of LL E2 was 1/20 of LL E1. Cells were not healthy in ConA FT 
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Figure 15. Bioactivity analysis of reverse phase HPLC fractions derived from 
the second preparation of lentil lectin eluate. 
The lentil lectin eluate was separated by reverse phase HPLC without 
passing through a gel filtration column. HPLC was performed as described 
for Fig. 10. Fractions 30-37 contains CDF /LIP-like activity. Fractions 22-24 
have weak ENK-, SP-, and VIP-inducing activity. 
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Figure 16. Bioactivity analysis of reverse phase HPLC fractions derived from 
the second preparation of ConA eluate. 
HPLC was performed as described for Fig. 10. Fractions 30-35 contain 
CDF /LIF-like activity. Weak inducing activity for ENK, SP, and VIP is 























































































































































Figure 17. Blockade of the activity in the ConA eluate, ConA flow-through, 
and HPLC fractions derived from the ConA eluate by an anti-CDF /LIF 
antiserum. 
Sympathetic neurons were cultured in the presence of fractions, with or 
without 100 11g/ml anti-CDF /LIF neutralizing antiserum (Ab), for six days. 
Adjacent HPLC fractions were pooled and analyzed together. The anti-
CDF /LIF antiserum blocks all activity in the ConA eluate (ConA E) and its 
HPLC fractions. Most of the activity in the ConA flow-through (ConA Ff) is 
also blocked by the antiserum. Residual YIP-inducing activity is still present 
in the antibody-treated sample, however. 
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APPENDIX. The cholinergic neuronal differentiation factor 
from heart cells is identical to leukemia inhibitory factor. 
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The Cholinergic Neuronal Differentiation 
Factor from Heart Cells Is Identical to 
Leukemia Inhibitory Factor 
TETsuo YAMAMoRI, KEIKO FuKADA, RuEDI AEBERSOLD, 
SIGRUN KORSCHING, MING-]1 FANN, PAUL H. PATTERSON* 
A protein secreted by cultured rat heart cells can direct 
the choice of neurotransmitter phenotype made by cul-
tured rat sympathetic neurons. Structural analysis and 
biological assays demonstrated that this protein is identi-
cal to a protein that regulates the growth and differentia-
tion of embryonic stem cells and myeloid cells, and that 
AG ROUP OF PR<YrEJNS, OFTEN CALLED C YTOKINES, REGU· late growth and differentiation m a wade vanery of nssues, both in the embryo and in the adult organasm. Some of 
these protems, such as imerleulun·6 (IL·6), were first recogniu:d for 
their effects on myeloid ceUs. The generaoon of the diverse array of 
myclord ceUs as under the control of cytokincs and proteins tcrrncd 
14-12 
stimulates bone remodeling and acute-phase protein syn-
thesis in hepatocytes. Tills protein has been termed D 
factor, DIA, DIF, DRF, HSFIII, and LIF. Thus, this 
cytokine, like IL-6 and TGF!l, regulates growth and 
differentiation in the embryo and in the adult in many 
tissues, now including the nervous system. 
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Brookl\'n, NY 11203 , S Korschlllg, Mu· Pianck-lmorut fur Enrw.cklungsbaok>gtc:, 
Abrc~Wlg Plwsaullu.chc Baolog>c, 0 · 7400 TubUlgcn 1, Fcdcnl RcpubLc of Gcrmmy. 
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hemaropoieric regularors. The genes for many of rhese prmcins and 
their receptors have been cloned, and consadcrablc informa[ion is 
availabk on their biological activities in VItro, as well as some data 
on their acrions in vivo in mousc and man ( /) . In the nervous 
system, it is also clear that phenotypic decis1ons can be conuolkd by 
facrors in the local environment, both in vitro (2, 3) and in siru (4-
6). It has been difficult ro characteri:z.c these neuronal dilfcrentiation 
factors becai.J..S(: the protein concentrations arc very low, and the 
assays arc lengthy and utili:z.c nondividing, primary neurons. None-
theless, a 45-ill glycoprotein thar can control neuronal phenotypic 
decisions has been purified from rat heart cell conditioned medium 
(7, 8). Ths protein, usuaUy referred ro as the cholinergic neuronal 
dilfcrenciation facror, acts on posunitotic , rat sympathetic neurons 
to specificaUy induce the expression of acctvlcholine (ACh) synthesis 
and cholinergic function, while suppressing catecholamine (CA) 
synthesis and noradrenergic funcrion (7-/0). The prorcin can also 
specificaUy alter ncuropeptidc gene expression in these neurons ( //), 
and it very likely alfccts the development of other types of peripheral 
and central neurons as well ( 12). It is termed a dilfercntiation facror 
becausc it controls phenorypic choices in these neurons without 
alfccting their survival or growth ( 9) . 
Using highly sensitive protein sequencing methods, we have 
obtained amino acid sequence data for seven peptides from the 
cholinergic facror. An affinity purified antiserum made against a 
synthetic peptide corresponding ro the NH2-tcrrninal 11 amino 
acids is able to specifically precipitate the dilfcrentiation activity, 
demonstrating that the sequenced protein is, in fact, the active 
facror. The amino acid sequences of the seven peptides arc nearly 
identical ro the corresponding peptides of the hcmaropoiccic facror 
that can inhibit the proliferation and induce macrophage dilfcrcntia-
cion of the leukemic myeloid M 1 cell line [leukemia inhibitory 
facror, LIF (IJ), which is also known as D facror and human 
macrophage dilfercntiation inducing facror, DIF ( 14) ), maintain the 
developmental potencial of embryo carcinoma cells and embryonic 
stem cells [ dilferenciacion inhibitory activity, D !A, and dilfercncia-
cion retarding factor, DRF (/5)], and support the proliferation of 
the leukemic DA-1a cell line (HILDA) (16), although the latter 
identification is in doubt ( /7). We used our amino acid sequence 
data and the available complcmenrary DNA (eDNA) sequence 
informacion to clone a eDNA for the rat prmein. Comparison of the 
sequences of the rat cholinergic facror with mouse and human LIF 
confirms their identity. In biological assays, recombinant murine 
LIF (recLIF) duplicates the cholinergic dilferentiation activity. 
Protein sequencing of the cholinergic factor and production 
of antisera. In order to sequence the NH2-tcrrninal of the choliner-
gic facror, we colleCted 40 liters of serum-free conditioned medium 
from secondary, rat heart cell culrures, and purified the protein (7). 
An estimated 0.5 to 0.8 t-Lg of the 45-ill protem was clccrroblotted 
onto an activated glass fiber filter, and sequenced on a Caltech gas 
phase sequenator at an initial signal of 18 pmol ( 18). Three separate 
samples yielded an NH,-terrninal, 14-amino aCid sequence of 
EPLPITPVSATXAI (/9) . To minimi:z.c the possibilirv that the 45-
ill band containing the cholinergic activn:y was contaminated by 
another protein, we isolated the band by SDS-polyacrylamidc gel 
elccrrophoresis (PAGE); the material in the band was eluted, 
chcmicaUy dcglycosylatcd with anhydrous hydrogen fluondc, puri-
fied further by SDS-PAGE, and sequenced (20). The chemically 
deglycosylated protein was approximately the same si:z.c, 20 ill, as 
that obtained after enzymatic deglycosylation with endoglycosidascs 
(7). The sequence obtained for the 20-ill band was EPLPITPV, 
identical to that of the intact protein. 
In order to be cenain that the sequenced protein was, in fact, the 
cholinergic facror, we obtained antisera roan 11- ammo acid peptide 
corresponding ro the NH,-rcrmmal sequence (21). These anriscra 
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Fig. 1. PrCC1p1ra0on of the 45-kD 
prmcm by mtascrJ w a synt.hcuc 
pepudc corresponding 10 the 
NH1-tcmun;U sequence of the 
protein. Rlbbit anuscra to the 
peptide coupled m Ulc earner 
protems KLH (lanes a 10 d), oval-
bumin (lanes c to h), or not cou-
pled to any cuner (lanes i and j). 
Th< parually purified facror ( Se-
phadcx fTacuon) was labeled wtth 
ul. and the labeled protcll\.S arc 
shown in the lmc next ro the 








proteins were incubated (21) " 'H.h antisera that had been incubated With the 
following blockers: free pepnde (lanes b, f, and j), peptide conjugar<d ro the 
appropmte carrier proteins (lanes c and g), KLH (lane d), ovalbumin (lane 
h), or was mcubarcd with anoscrum ro ovalbumin (lane I) or withour any 
antiserum (lane k) . The immune compkx« were adsorbed by protein A-
Sepharosc, washed, eluted, and analyzed by SDS-PAGE. A similar experi-
ment, with affinin·-purificd •mibodies, y•elded similar results. 
Table 1. Precipitation of cholinergic activiry by antibodia to peptide. 
Immunoprecipitation experiments were performed as in Fig. 1 (21), with 
antibodies purified by peptide affiniry-column chromatography. When anti-
bodies were mcubated with frcc peptide, the sample was cxrcnsivcly dialyz.ed 
after the incubation to remove free peptide. The immune complexes were 
centrifuged and prOteins were eluted from the pcUcts by acid trcaancnt. 
Antitxxlics could also be: eluted by this treatment. However, addition of 
excess peptide ro the eluate before neutralization to block rebinding of the 
eluted antitx>dics to the eluted faaors resulted in no change in cholingeric 
activity. Both the eluates from the immune pcUets and the immune 
supemarants (Sup) were added to sympathetic neuronal culrures from days 2 
ro 16, at 2-day intervals. The ratio of rransminers produced (accrylcholinc to 
c.atccholaminc~ ACh/CA) (7) is a quantitative measure of the rwo transmitter 
systems and re6ecrs, in part. the levels of choline accrylrransferasc and 
tyrosine hydroxylase, respecti.-cly (9). 
Addition ro 
Sephada fraction 
Antibodies to peptide- KLH 
Antibodies to peptide-KLH plus free peptide 
Antibodies to KLH 










(and affinity purified antibodies) could precipitate both the 45-ill 
protein (Fig. 1) and the cholinergic acrivity (Table l) (22). Prior 
incubation of the anriscra with the synthetic peptide prevented this 
precipiration, indicating that the protein of inrerest had been 
sequenced. The antisera to the NH2-rerrninus recogni:z.cd the native 
protein, suggesting that this portion of the protein is exposed on its 
surface. The prccipirates in Fig. I also reveal other, weaker bands 
ncar the 45-ill protein, and addition of the synthetic peptide 
abolished the precipitation of aU of these bands. Since the 45-ill 
protein has several glycos\"1 chains (7), the additional bands in the 
prcCipirated fractions may be glycosylation variants of this protein or 
the result of partial prorcol,"tic degradation. 
The extremely high degree of degeneracy in the codons for the 
NH2-tcrrninal sequence made cloning by oligonucleotide screening 
difficult; we therefore purified a large amount of the cholinergic 
factor from 35 lirers of conditioned medium (2J) and determined 
the sequences of a number of internal pepcides (24). The fotlowing 
sequences were obtained: LGQGEPFPNNVDKL; SQLAQLPVV; 
LGASL; LVE; EAFE; LIAT; and EPLPITPV. The facr that one of 
the peptides corresponded to the same NH,-rerrninal sequence 
already obtained showed that the tryptic peptides carne from the 
same protein. A search of the computer database revealed a close 
match of each of these peprides with a corresponding peptide in the 
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munne and human UF-DIF-D-f•aor-DLA-DRF proreon (IJ), 
wh1ch we refer to as U F. 
C loning the cON A for the cholinergic factor and irs identity 
with LIF. To determine the correct sequence for rat cholinergic 
faaor or LIF, we used the polymerase chaon reacnon (PCR), with 
rl if ATCAACCTCTTCCCCCCACCCATTCTCCCCCTACTCCTC---ATTCTCCAC 48 
IDl if ATCAACCTCTTCCCCCCACCCATTCTCCCCT CCTCC 
RLIF LeuLeuLeu---lleLeuHis -7 
M.LIF HetLysYalLeuAlaAlaClylleValPro LeuVal 
HL!P Val ---Val 
.. 1 
rl if TCCAAACACCCCCCACCCACCCCCCTTCCCATCACCCCTCTAAATCCCACC 99 
mli£ T 
RLIF TrpLysHisClyAlaClySerProLeuProileThrProValAsnAlaThr 11 
HLIP 
HLIP 
rl if TCCCCCATACCCCACCCCTCTCACCCCAACCTCATCAACCACATCAACACT l 50 
~li£ T A C A 
RLIF CysAl aIl eArgH is P..roCysH i sCl yAsnLeuHetAsnClni leLysSer 28 
HLIF Asn 
HLIF Asn ArgSer 
rli£ CAACTCCCTCAACTCAACCCCACTCCCAATCCCCTCTTTATTTCCTATTAC 201 
1Dl if A c T c T c 
RLIF Cl nLeuAlaClnLeuAsnCl ySerAlaAsnAlaleuPhe I 1 eSerTyrTyr 45 
MLIF 
HLIP Leu 
rlif ACACCTCAACCCCAACCATTTCCCAACAACCTCCATAACCTATCTCCCCCA 252 
•li£ A C C A T 
RLIF ThrAlaCl nCl yCluProPheProAsnAsnVal AspLysLeuCysAl a Pro 62 
MLIP Clu 

























lle Val Thr Cly 
ATCACCTCCCATCACAAAAACCTCAACCCCACTCCCCTCACCCTCCACATC 
C C CCT C C 
ILeThrTrpAspClnLysAsnLeuAsnProThrAlaValSerLeuClnile 
Arg Val Val 
Arg Ile Ser Leu HisSer 
405 
113 
rl if. AAACTCAATCCCACTACACACCTCATCACCCCCCTCCTTACCAACCTCCTT 456 
mli£ C T T C C T 
RLIF Ly.sLeuAsnAl aThrThrAspVa 1 HetArgCl yLeuLeuSerAsnVa L Leu 130 
HLIF lle 
HLIF Ala lleLeu 
rl if TCCCCTCTCTCCAACAACTACCATCTCCCCCATCTCCATCTCCCCTCTCTC 507 
ml if C C ACC 
RLIF CysArgLeuCysAsnLysTyrHisValClyHisValAspValProCysVal 147 
HLif Arg Pro 
HLIF Se r ThrTyrCly 
rl if CCCCACAACTCTACCAAACAACCCTTCCAAACCAACAACTTCCCCTCCCAC 558 
mlif C CA A T 
RLIF ProAspAsnSerSerLysCluAlaPheClnArgLysLysLeuClyCysCln 164 
MLIF HiJ Asp 
HLIF Thr Cly AspVal Lys 
rl if CTCCTCCCCACATACAACCAACTCATAACTCTCTTCCCCCACCCCTTCTAC 609 
ml if T CTCATMCTCTCCTCCTCCACCCCTTCTAC 
RLIF LeuLeuClyThrTyrLysCln 180 
HLIF VallleSerValValValClnAlaPheTER 
HLIF Lys tle Ala LeuAla TFR 
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oligonucleoudes corrcspondmg ro the s1gnal pepudc and COOH-
terminal sequences of murine and human LIF (25). The rar, murine, 
and human ammo acid sequences arc al1gncd in Fig. 2, and the 
correspondong pepudcs thar were sequenced arc underlined. AJ. 
though the COOH-rermmus of the rat sequence is nor yet complete, 
there 1s a strong homology with both the murine (92 perccnr 
1dcnt1ty) and the human (82 perccnr identity) LIF amino acid 
sequences. h 1s srnking that there arc highly nonconservativc 
differences between all three species at residues 103, 113, 146, ISO, 
and 152, and a C\'Stc1nc res1duc (at 146) is presenr only in the rat 
sequence. The d1ffcrcnccs beewecn the deduced rat amino acid 
sequence (F•g 2) and sequences derived from the tryptic peptides 
(given above) are found primarily in the NH2-rcrminal ends of the 
pepudcs and at purarive N-glycosylarion sires. These arc sites known 
to present difficulues for accurate amino acid sequencing. 
In order to confirm thar the cloned produa of the murine LIF 
( IJ) docs indeed have cholinergic neuronal differentiation activity, 
we obtained an authcnuc sample of this material (26). Purified 
murine rccLIF, expressed in Eschmchio coli (27), was added ro 
culrurcs of nconaral rat sympathcric neurons, and ics cffccrs on the 
choice of transmm:er phenotype were assayed; LIF was able ro 
mducc ACh synthesis as wcU as suppress CA synthesis ar low 
concentrations (Table 2). These arc the activities observed for the 
cholinergiC diffcremiarion faaor purified from heart ccU condi-
tioned medium (7). 
We have presented several lines of evidence ro demonstrarc that 
the proteins prcv1ously called Ll F and the chol.incrgic neuronal 
diffcrcnuarion faaor arc the same molecule. The purified neuronal 
faaor and rccLIF have the same biological activity when tested with 
culrurcd neurons. The slight differences between the amino acid 
sequences obramed from the tryptic peptides and the deduced 
sequence for rat LIF can be attriburcd ro limirations of prorcin 
sequencing methods. In addition, Gearing<~ ol. (13) detected only 
one gene on Southern blocs of murine genomic DNA digesred with 
nine rcsrriaion cndonuclcascs and probed with a LIF eDNA ar both 
high and low stringencies. 
The vanous names that have been used for this protein may 
deserve reconsideration. For example, dtc previous term used with 
neurons, cholinergic diffcrcntiarion factor, is inappropriate for ewo 
reasons. First, recent resulcs w1th pure faaor and rccLIF on culrured 
sympathcuc neurons show that the protein specifically induces the 
expression of several ncuropeptides in addition to the biosynthctic 
enzyme for acetylcholine (II) . Second, several reports on the effects 
of the prorem on myelo1d ccU lines and embryonic stem ccUs have 
led ro the m<roducnon of ar least five different names. Furthcnnorc, 
the protein has been •mplicared in bone remodeling and in the 
mduruon of acute phase plasma prorcin synthesis on liver cells (14, 
17, 28). 
Although the role of the cholinergic faa or in the normal develop-
ment of the nervous system IS nor yet known, the faa that 
Fig. 2. The nuclco11de sequence of the codmg region of rat LIF (rloj) and IU 
deduced >.mmo •c•d sequence (RLIF) ore compared to those of mouse (mlif, 
MLIF) and hwnan (HLIF), whiCh h•ve been dcscnbcd culler (IJ). The 
suggested NH2-tcrnunaJ rcs1duc as dc.s1gnatcd as + 1 wath an arrow. MLIF 
has an a<klitionaJ ammo ac1d 111 the s1gnal sequence compared to the rat and 
hwnan sequences. t:has cLffcrcncc as mdJcucd by the dashed lines. Serine is 
suggested robe the NH,-rcmunal rcs1duc because our NH,-tenninal amino 
acid sequencing data y•cldcd one rcs1duc before proline, and Gly-Scr is a 
Uk.cly sagnal clcav<tgc sate The rcg1ons of the deduced prOfcm that corre-
spond 10 the pcp(ldcs obumcd tn our 3JT\UlO X1d scqucncmg cxpcrimcnu 
vc underlined The fir1t a.nd bst 30 nudcoudcs concspond ro the primers 
wed for the PCR rcac[lons and were taken from the mouse or hwnan 
scyucnccs 
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Table 2. Chohncrgte datfcrcntlaflnn :;at;[l\'lf'\' of l.ll- Svmpathcuc neuron\ 
were grown for 2 '' cck.s m the pn.·\Cncc ol I 00 p:rccm volume cqua\'~lcnts of 
heart ccU condmoncd mcd1um , rc~ombmam (rcc) munnc LIF. or no 
addmons other titan the usual mcdaum consurucms The conccntrauon of 
cholmcrgac factor prmcm m l 00 pcrccnr heart cell conditioned mcd1um as 
csumatcd to be between 10 omd 100 ng/ml Transmancr synthcsts from 
rachoacU\'C precursors was assayed as dcscnbcd (7); the d:ua arc expressed as 
means :!: SEM, wath ,. = 4 The ACh/CA ,-a.Jucs arc the means of the rauos 




rccLIF ( 1 ng/ml) 
rccLIF ( 10 nglml) 
Hcan ccU condmoncd mcdJwn 
:\ cu' af\· per neuron (fmoUhour) 
ACh 
004:!:001 
0 20:!: 0 04 
1.30!: 0 02 
3 20 :!: 1 25 
CA AChiCA 
2.70:!: 0 41 0.02:!: 0.01 
1 10 :!: 0 23 0.29 :!: 0 13 
0 50 :!: 0.08 2. 70 :!: 0.45 
0 52 :!: 0 16 6 60 :!: 0.35 
sympathcnc neurons [and poss1blv scnson• and sp1nal cord neurons 
as well (12)] show a smlung and speCific response to It suggests that 
they have receptors for the proccm as well as a compatible second 
mesxngcr system. lr is tmportant ro asccnam where these rc:ccprors 
arc localized dunng neuronal development. Although there is good 
evidence for the localized produwon of a phcnotype-specif)•ing 
factor by a target tissue m s1ru (6), all types of neurons that innervate 
a given target do noc respond Similarly to that environment. Thus, 
the known diversity of neuronal phenotypes could be due to 
different combinanons of msrructive cues present ar various loca· 
cions and to diffcrcnual responsiveness to a gtvcn mu;rurc of cues at 
any one Site. The availabiln:y of the appropnatc genes, protcms, and 
antisera should lead to clarification of the Similarities and differences 
among the various factors that have been reported to mfiucncc 
neuronal phenotype. ThiS mcludcs not only the cholinergiC factors 
(29), but other neuronal <tiffcrcntlatlon actiVIrics as well (JO), 
because the choh.ncrgiC factor Itself can rurn on (and off) the 
expression of several <tiffcrcnt neurotransmitters and ncuropeptidcs 
(11) . 
If the same molecule influences the differentiation of mvel01d, 
neural, and other cells, how then IS the spenficity of 1ts conirol on 
each of these <tiffcrcnt systems mamtamcd? S1dc effects, if any, could 
be averted if the d!stributlon of the factor 1s h•ghly localized, or if the 
various systems arc responsive durmg d1ffcrcnt developmental pen· 
ods. There arc other examples of proccms that arc potcntlallv 
important for the development of both the 1mmunc and nervous 
systems. lntcrlculun-1 ( IL-l ) and poss1blv IL-3, and receptors for 
IL- l , -2, and -4 arc found m the bram and m neural cell lines (31, 
32) . IL-l stimulates glial proliferation, somatostatin, and ncn•c 
growth factor (NGF) production, and It h:IS transmmcr·hkc effects 
on neurons (33). IL-2 stimulates ohgodcndroghal proliferation and 
maruration as well as cortKOtropm release from p•runary cells (32). 
Gamma-mrcrfcron can c:nhancc asrrocvtc maruranon and mdirccrlv 
increase the cholinergiC diffcrcntlatl~n of cu lrurcd spmal cord 
neurons, and rat interferon enhances the cxprcss•on of accrylcholmc 
receptors m culrurcd rat myorubes (34). B cell Stimulatory facror 2 
(or IL-6) IS detected m ghal cell lmcs and can mducc ncuntc 
extension and voltage-dependent sod1um channels m PC12 cells 
(35). Conditioned mediUm from acuvatcd lvmphocvtcs can mam-
tain sympathcnc neurons in culrurc, and bram macrophages can 
release NGF m vnro (36). NGI' can promote hcmopo•ctiC colony 
growth and <tiffcrcntianon, and lflJ<Cnon of NGF mto neo natal rats 
increases the number of mast cells (37) . In add1non, subsets of 
thymocytes and lymphocytes express NGF receptors (37). In fact, 
there arc manv parallels m the questiOns and phenomenology of 
hncagc deciSions m the neural crest and hcmatopolc!lc svstcms (38) 
Our data add a new dlJTlcnsion ro this overlap ~ \'en• dJttCrcrn lmc.lgt: 
lj DECEMBER 1989 
choiCes mJ\ be (Ontrollcd b)' thl· sm1c: molecules 
'''''~' .1ddcd "' l"•··~f: \Ve ha\'c dcu:nnmcd the 3' sequence of the rat 
cDS.\, .mJ th< fin•! 30 bases arc GTC\TIAGTGCGGTGGTCC. 
AGGCCITCf.\G 
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anutxxLc.s tO the CUTKr wu > 10 I , on the bu1\ of band1ng cun·~ wuh the 
pcpudc Mld lhc c.arncr proccms u :umgcns 
22 Panu.lh· punficd cholmcrgK fJcror wJ.s K>dmatcd w•th the Bohon·Humcr r-eagent 
(7) and used as 2 tnccr The Scphadn fncuon, conumang 2 x 10, cpm of rucu, 
was tint mcub:ucd wnh prcmvnunc sc:nun (0\'Cm•ght at 4•C) 111 the presc:ncc of 
proc:cuc mhabuon (I mM phcnvlmcth\'lsuJfonvl ftuondc (PMSF), and Tr.uvloJ, 
kupcpun, md rurkcv egg whnc trypsm anhabuor at 2 ~glml each). The complcx.C's 
that bound to pr<:mununc S<rum were ;~bsortxd b\• protc:m A Xpharosc tn PRS, 
0 .02 pcrcc:m U1dc, 0 01 pcrHnt polycth\-lcnc gtyrol (PEG) for 2 hours, and were 
removed bv ccmnfugauon The supcrnumr was thc:n •ncubaccd ovcrn•ght at 4•c 
wnh anuscrum to the pcpncks (whtch h2d bc:cn mcubatt'd ovcm•ttht at 4•c wuh or 
WJd'K>\n blodtcn) m the prucncc of protc~ mh1buors and rcprc:Cipturcd The 
protem :\-Scpharo~ bcarmg mvnun<: complexes were washed once With I"'BS. 0 02 
percent uuJe, 0 01 pcrcem PEG. four tUlleS .,...,th tugh n..lt buffer (0 IM c:ns HCl. 
pH 7 8 , 0 5.\-f NaCI. 0 02 percent u.ade, .lnd 0 01 percent rEG). and then wnh 
PBS. u1de . .tnd PEG Immune complexes were eluted by 0 1M glycme HCI, pl-l 
2.5, 0 01 percent PEG and neutn.hz.c:d promptJv wnh 1.\f ms· HO, pH 8 These 
rcsuJu .,.. ere reponed 10 an :~~bsu:~~ct ( K Fultad:~~, SO< Nhul'Jtl AbJtr 12, I 06 S 
(1986)] 
23 lbc chohncrgtc factor wu punficd as dc.scnbcd ( 7), ucept that the prec1p1t:JtK>n 
w1th 60 percent .unmomum suJf:~~c wu ommcd The punfiouon was monitOred 
by pra:•pu:aaon of the Iodinated factor (wh1ch h.:Jd bttn :added to the prepanuon) 
wnh the :a.n~rum to the factor Thu procedure works weU only for the CM· 
ceU~ l.nd Scph:adc.x fncuons 
24 1bc prcp:a.r:auon :and scquencmg of tntcm.a.l pcpudcs followed the pnxocol of 
Acbcnold "•I [ R H A:cbcrsold. J Lca-·m, R. A. Suvcdra. L E. Hood, S. B. H 
Kent, PtO< "'"' A"d So. U S A M. 6970 ( 1987) J Putially punlicd ehoLncrgoc 
f.t.ctor {2 m 3 ~g) wu scp:antcd from conu.rrun:atmg protem by SDS· rAGE. The 
proteliU were truufcrrcd to muoceUulos.c, md the band cofTCSpondtng to the 
cho1merg•c factor wu digested w1th uypsm on the ruuoceUulosc The n:sulung 
pcpcdcs were relusc:d liUO the supcm:aum and scp:antcd by high pcrformance 
bqwd chromnognphy (HPLC) The most protmnent pcpodcs were: then sc· 
qucnccd. 
15 Four olJgomcn were used co obt:am the PCR fn.gment of rat Llf (1) a 21 · 
::U"!:ndce~n°~r"~r"~~T~r~2~,c~~~~~dr~d.fc~~~ 
st:a.rtulg from the :anwcnsc sequence of the stop condon of the munnc and human 
factor; (au) 30 nt (ATGMGGTCITGGCCGCAGGGATIGTGCCC) eorre· 
sponding to the s· end of the 11gn.a.l pcpode of munne LlF. (av) 30 nt 
(crAGMGGCcrGGc"C~CACITATGAC) eorrapondmg to the 
COOH·temunw of the prote&n Complementary DNA was symhcsazcd from 
potyacknyl:ucd culrum:l heut ccU R.N'A ..... 1th a MuLV (munne kukmua varus) 
rcvcnc traruenptuc lut (BRL) .llld oligomer (u) u the pnrncr. Dunng the first 30 
cycles of the f'CR reacuon {94•C for I rn.mute, 50-<: for 2 trunutcs., and 72~ for 3 
trunutcs; R. K Sulu "•I. S<""" 239, 487 ( 1988)] the oLgomcn of (1) ;and (u) 
were the pnmcn The tint PCR product of approxunarely 600 bp was pwlfied and 
used a.s lhe remplatc of the sn:ond PCR re:acnon wtth oUgomcrs of (1i1) and (•v) 
1hc second I"CR product conn ..mcd a m:a)Or band of lhe expected Sll.C (609 bp) '" 
agarosc: gel elcctrOphor"csls. The fngmcnt wu sutxJooed to the vector of PGEM· 
3zf(-) (f'romcga), :and aru.lyzed w1th the ~qucnuc (US. BtOChmunJ) svstem 
Both suand.s were sequenced not onlv wnh the T7 and SP6 pnmcrs, but Uso wu:h 
olJgomcn ( 111) :and (I\') :and thrtt amemaJ sc:quences (TITITCfGATCCCAGGT· 
GAT, TICCCCITGAGcrGTGTMTAGG.-\A. GAGMGACCMGITGGTC· 
GAGCrGTAl 
26 Tile authcnuc SMnpk ..... u obumed &om D Metcalf (sec JJ) 
2 7 0 . P Ga.rmg tt a/ , B1otultnology. &n pres.5. 
28 H 8:Jwmnn and G G Won£!:. J /mmt.mo/ 143, 1163 ( 1989); D Metcalf and 
D P. Gc.umg. Prot ,\iatl Anad St~ [.; _s .-\ 86. 5948 ( 1989) 
29 ~ Brook.c:;s, D R Bun. A M Goldberg, G G Bterk.ampcr. 8""" Rts 186, 4 74 
(1980); E. W Godfrcv, B K Schncr, r G Nelson, O.v Boot 77,403 (1980), E 
H•wrot,obod 74, \36(1980);R NtSha.ndD K Berg.} N""""' 1,505( 1981 ). 
M . Mamhorpc, W Luvten, F .\if Longo. S Varon. 8nJut RtJ 267, 57 ( 1983), G 
Barb1.11, M M:anthorpc, S Varon. J .'\n•rodttm 43. 14-68 (1984), C E Hen 
I.J-16 
dcrson,:0.1 llu .. het.l r Ch.11tgeux.Dr•• £J .. ,f 10.,336(1984),) E.AdlerUldl 
8 Bladt, flrl'• \.ul ~ • .~J ~' {} S .-\ 82 . .f 296 ( 1985); E. J Wolmsky and P Jl 
rancnon.} ,,,, •. ,, S. 1509 ( 1985) . L ~t K.aufman, S R Barry, J. N Barren, 
1b•J, p 160, R G Smu.h. K V:~~c;a , J M~o..\hnaman, S H Appel. 1brd 6 , 439 
(1986}, \" Won~ .llld J .-\ Kessler, PriX ,'\a1/ :\ tad Sn US A 8-4 ,8726 ( 1987}; 
A Achnon and L' Ruush<1us.cr,j Cd/ B·oi 106,479 (1988); I. A Hendry, C E. 
Htll. D Belford. D J \Vntcn, 8n1m Rn 4 75, 160 ( 1988), J l McManaman, F 
G Cuwford. !> S Stc,\art, S H Appel.) Brol Cltt'm 163.5890 ( 1988); J-C 
M:arunou, F Btcrer. .\ L \' Th:u, M J Wdxr, I:Xv Bnm• RtJ 47,151 (1989); 
S SaJc.bc, ~1 ScnJmer, H Rohrer,) Cdl 8~<•1 108, 1807 (1989) 
30 J A Kessler. I E \~kr, \\' 0 BcU. I 8 Bll,k. Nf'11romrntt 9, 309 ( 1983)~ J A 
Kessler, •hrJ 15 s.r i 1985), D \\' Y S:lh md S G. M:auumoto,J Nrurour 7, 
391 ( 198/l. I r D.nts .. \1 L Epstem. Dr~• B•ol 124.512 (1987) 
31 K S Fret. S Bo..imcr. C Sch \.lo·erdcl, A Fonusu. J lmmwttol 135,4044 (1985)~ 
1b1J 137. 3521 11986). W L F:arn.r. M \'mocouc, J. M . HaU, Blood 73, 137 
(1989); \\' L F.ur.u . r L Nlu.n, M R Rutf. J M Ht.ll. C 8 Pen,) lmmu11ol 
139. 459 ( 198;' ,, J W Lowenthal~~ a/,) Jm,umol 1•0. 456 ( 1988); C D 
Brcder. C A Dm.ucUo. C. 8 Sapcr. Sm11<t 240.321 ( lc;88). 
32 E S Bemenaste md J E MemU, Satwr~ 311.610 (1986). L. R. Srruth, S L 
Brown, J E Bl:aJo..:l.. J ·'~uro,mmw11t1l 11 , 249 ( 1989) 
33 A Fontana. R Dubs. R ,\tercham. S BaJsmgcr, P J Grob, J N nmnmmunol 2 , 
71 (1982), .\ Fonuru. 1: 0t:z.. A. L dell' eel<. r ) Grob, obod, p 81, D 
Lmd.holm, R Hewm • .nn. ~~ Meyer, H Tlxxncn, Norur~ 330, 658 (1987); D 
Gu..Wan, K \' ac:~~, B Johnson, J ,'\'nuoJ(I Rts 21, 487 ( 1988): D G•uh:a.n, D . G 
Young.) ll'ood~ ud. D C Brown, l B l>elunan, j Nnmsco 8, 71:19 ( 1988),) 
E. Merrill and K. ~huu.sham:a. ) 81ol R~t HMt~ou Agff1tJ 2, 77 ( 1988); D E 
Scuborough. S l lee, C A DanueUo, S Reachlut, &v/«n...logy 124, 5-49 
(1989}; T Hon ~~ .J/ Br.Jm R~s Bwll 20, 75 (1988) 
J.4 l Edmun. l \\'aunn, D C.delh, A C K .. o. O.v. Bool 132, 375 ( 1989), r. 
Andre tt al, J 'rm.,,t, R~s 19, 297 (1988) 
35. K Yuuk.:awa n ol. E\180 J 6, 2939 ( 1987). T Satoh n of, Mol Cdl 81ol 8, 
3546 ( 1988) 
36 Y Gozes, ~~ .~ ,\tosk.O\\'Itz. T B Strom, I Gozc.s, ~~~ Brottt Rts 6, 97 (1983); 
M .\hl!:at. R Houh!.ane, r Brachct., A. Proch.lma.. ~~~ 81ol 133,309 ( 1989) 
37 L. Aloe :and R Lc;, .~tom:aJCiru, Bra,, RtJ 133, 358 ( 1977); A Cananco, in 
Mol~rulor A.spur, ,_,· .'tt4rl'b•ology, R ~,-~lonuaJCiru, Ed (Spnnger Verb.g, 
Berhn, 1986). pp 31-36, H Matsud:~~, M D Coughlin, J 81encrurock, J A 
Dcnburg, Prt1! '.lrl .-irdd SCI U.S A 85, 6508 (1988); 8 MorgM~, L. \V 
Thorpe. D . . \1uchem. J R Perez Pokl,) _,tvrou' RtJ 23, 41 ( 1989)t I 
Sn.rn<nl<Dnc. E .\ Cluk. B Seed, £,\180 j 8. 1403 (1989) Thcr< ~also the st.U 
wuesolvcd ISSue of the role of .. neurolcukJ.n" m neunl dcvdopment (M Ouput t1 
•I, S•r•" 332. 45~ ( 1988). r f.,k. J I H Walker. A A. M Rcdrrull. M J 
Morgan, •bed. p 455. ~~ E. Gum~·. 1bed, p 456) 
38 D J Anderson. -"""''" 3. I (1989) 
39 We thank D .\1etc.ill :and coUc.agucs u the \\'.a.lter and E..lJ.z.a Hll! lnstJNte for 
Medical Rc.sc:arch m .\1cl00ume for the rccLIF; .Vt Tanouye and M. Ram:asw:JJT\.1 
f<>< hdp With the rcR o:-;.~ unpLfiemon, T HWU..p.Ucr ;and D l•d:son fO< help 
wtth the computer scuchc.s. D Anderson, H ~aw.a, and M R:JO for adviCe, D 
Mc[)o....·eU for help "1th the prepanuon of ussue cuJrurc m:Jteri:ah, J Carnahan for 
NGF. J Frost .. \1 R\Jer, and R Pmman forcondmoned mcd!wn, S. Horvath :and 
coUeagucs for olJgonudcoode and pcpude svnthcsas, 8 }emof't·N•Ixn and M 
Aranda tOr help \.lo'ath nucletc aetd .scquencmg. :and S Ou for help w1th anoboches 
Supponed b\ ~~~CDS (J:a"!tS Neurosctence ln\esugator Award), a McKn1ght 
Foundauon ~ewosc•en..:e Research ProJect A \.I. .ud. a Luc•Ue r Markey Channble 
Trust Devdopmenu.J B•ologv grant, che Gu.sunu and Lowsc rfe•ffer Research 
Foundmon. and the Joseph Dro\.\"Tl Foundacon (PH r .); bv the MwcuJa.r 
0\·suoph\ :\nocuoon .llld Dn:autonorru:a Foundaoon (KF.); by the A.mc:ncan 
Heart .-\.ssocut•on md the Ono H~n ~led~Ue 1S K ), by the Ahheamcr's Duc:uc 
.llld Rclucd Dlsorden .\.ssocuuon (T r I; .l s\.1, IS.S Nauooa.J Foundauon Fellow· 
ship 1 R A. 1. Utd lhe ,\l•n•strv ofEducauon, T:a1\~an. R.O.C.. Utd the Hek:n G. and 
Anhw ,\t~wn Found:auon (.\1 -1 F.) 
15 September 1989. l .:ceptcd 14 :"'o,embcr 1989 
M;IENC~ .• VOL 2.+0 
